a:1373:{s:12:"R-DME-110478";s:25:"Insulin signaling pathway";s:12:"R-DME-110523";s:21:"TOR signaling pathway";s:12:"R-DME-110524";s:24:"DINR-mediated activation";s:12:"R-DME-110526";s:35:"Insulin receptor mediated signaling";s:12:"R-DME-209155";s:30:"Phosphorylation of AXN and APC";s:12:"R-DME-209159";s:39:"Assembly of the CI containing complexes";s:12:"R-DME-209171";s:85:"Peptidoglycans (PGN) bind to a peptidoglycan recognition protein receptor, PGRP-LC/LE";s:12:"R-DME-209190";s:21:"Phosphorylation of CI";s:12:"R-DME-209209";s:43:"Formation of the activated receptor complex";s:12:"R-DME-209214";s:22:"Phosphorylation of SMO";s:12:"R-DME-209228";s:69:"Formation of the activated STAT92E dimer and transport to the nucleus";s:12:"R-DME-209266";s:43:"Peptidoglycan bound PGRP-LC/LE oligomerises";s:12:"R-DME-209338";s:38:"Assembly of the 'signalling complexes'";s:12:"R-DME-209360";s:51:"Ubiquitination and proteolysis of phosphorylated CI";s:12:"R-DME-209387";s:22:"Phosphorylation of ARR";s:12:"R-DME-209392";s:16:"Hedgehog pathway";s:12:"R-DME-209394";s:63:"Transcriptional activtion and repression of REL-68 target genes";s:12:"R-DME-209396";s:22:"Phosphorylation of ARM";s:12:"R-DME-209397";s:52:"Formation of the cytosolic BSK 'scaffolding complex'";s:12:"R-DME-209400";s:56:"Transcriptional activtion by phosphorylated DL/DIF dimer";s:12:"R-DME-209405";s:16:"JAK/STAT pathway";s:12:"R-DME-209406";s:41:"Degradation of NF-kappa-B inhibitor, CACT";s:12:"R-DME-209407";s:31:"Transport of ARM to the nucleus";s:12:"R-DME-209409";s:72:"Formation of the nuclear AP-1 transcription factor 'scaffolding complex'";s:12:"R-DME-209412";s:16:"Wingless pathway";s:12:"R-DME-209413";s:37:"Assembly of the 'destruction complex'";s:12:"R-DME-209421";s:31:"Transcription activation by ARM";s:12:"R-DME-209425";s:54:"Transcriptional activtion by AP-1 transcription factor";s:12:"R-DME-209438";s:61:"Formation of the PGN:PGRP-LC/LE receptor 'signalling complex'";s:12:"R-DME-209440";s:107:"Recruitment of the 'destruction complex' to the receptor complex, the degradation of AXN and release of ARM";s:12:"R-DME-209441";s:35:"WG ligand not bound to FZ receptors";s:12:"R-DME-209442";s:52:"Formation of the trans-membrane 'signalling complex'";s:12:"R-DME-209446";s:45:"N-HH ligand not bound to PTC receptor complex";s:12:"R-DME-209447";s:60:"Activation of the IkappaB kinase complex, KEY:IRD5 dimer:KEY";s:12:"R-DME-209449";s:12:"Toll pathway";s:12:"R-DME-209452";s:41:"N-HH ligand bound to PTC receptor complex";s:12:"R-DME-209459";s:11:"Imd pathway";s:12:"R-DME-209461";s:52:"Ubiquitination and degradation of phosphorylated ARM";s:12:"R-DME-209465";s:47:"Catalytic processing of the nuclear factor, REL";s:12:"R-DME-209469";s:31:"WG ligand bound to FZ receptors";s:12:"R-DME-209471";s:42:"Formation and transport of the N-HH ligand";s:12:"R-DME-209472";s:28:"Assembly of receptor complex";s:12:"R-DME-209478";s:24:"Dephosphorylation of BSK";s:12:"R-DME-210671";s:45:"Transcriptional repression by nuclear factors";s:12:"R-DME-210675";s:58:"Transcriptional activation by phosphorylated STAT92E dimer";s:12:"R-DME-210688";s:40:"Dephosphorylation by PTP61F phosphatases";s:12:"R-DME-210693";s:76:"STAT92E dimer dephosphorylated in the nucleus and transported to the cytosol";s:12:"R-DME-214397";s:60:"Assembly of the PGN:PGRP-LC/LE receptor 'signalling complex'";s:12:"R-DME-214399";s:134:"Activated IkappaB kinase (IKK) complex, Phospho IRD5:KEY dimer, phosphorylates REL in the PGN:PGRP-LC/LE receptor 'signalling complex'";s:12:"R-DME-214411";s:70:"REL binds to DREDD in the PGN:PGRP-LC/LE receptor 'signalling complex'";s:12:"R-DME-214416";s:59:"Phosphorylated REL is cleaved by and dissociates from DREDD";s:12:"R-DME-214842";s:96:"DL and DIF homodimers bind to TUB and phosphorylated PLL in the TL receptor 'signalling complex'";s:12:"R-DME-214844";s:104:"DL and DIF homodimers complexed with CACT are all phosphorylated in the TL receptor 'signalling complex'";s:12:"R-DME-214862";s:82:"Activated PLL kinase is autophosphorylated in the TL receptor 'signalling complex'";s:12:"R-DME-214863";s:67:"Adaptor protein complex binds to TL receptor at the plasma membrane";s:12:"R-DME-214869";s:95:"Phosphorylated CACT, DL and DIF homodimers dissociate from the TL receptor 'signalling complex'";s:12:"R-DME-214874";s:63:"PLL kinase binds to TUB in the TL receptor 'signalling complex'";s:12:"R-DME-216119";s:16:"Activation of CI";s:12:"R-DME-216167";s:22:"Nuclear CI is degraded";s:12:"R-DME-216217";s:17:"Activation of SMO";s:12:"R-DME-350368";s:36:"Activation of RHO1 by FZ:DSH complex";s:12:"R-DME-350369";s:56:"Negative feedback loop regulates asymmetric localisation";s:12:"R-DME-350376";s:40:"Activation of RAC1:GTP by FZ:DSH complex";s:12:"R-DME-350379";s:54:"Homo-/heterophilic binding of transmembrane components";s:12:"R-DME-350384";s:38:"Myosin phosphatase dephosphoylates SQH";s:12:"R-DME-350407";s:17:"RHO1 GTPase cycle";s:12:"R-DME-350411";s:64:"Formation and asymmetric localisation of transmembrane complexes";s:12:"R-DME-350416";s:34:"Regulation of non-muscle Myosin II";s:12:"R-DME-350431";s:28:"Planar Cell Polarity pathway";s:12:"R-DME-350480";s:34:"Activation of non-muscle Myosin II";s:12:"R-DME-390023";s:29:"Subcellular localisation of D";s:12:"R-DME-390024";s:26:"Negative regulation of WTS";s:12:"R-DME-390089";s:38:"Formation of the Hippo kinase cassette";s:12:"R-DME-390098";s:43:"Phosphorylation-dependent inhibition of YKI";s:12:"R-DME-390115";s:26:"Negative regulation of HPO";s:12:"R-DME-390146";s:19:"Hippo/Warts pathway";s:12:"R-DME-390150";s:30:"DS ligand bound to FT receptor";s:12:"R-DME-390178";s:34:"DS ligand not bound to FT receptor";s:12:"R-DME-390193";s:33:"Transcriptional activation by YKI";s:12:"R-DME-390197";s:25:"Negative regulation of TH";s:12:"R-DME-432395";s:18:"Degradation of TIM";s:12:"R-DME-432408";s:36:"Transcription regulation of cwo gene";s:12:"R-DME-432490";s:29:"Nuclear import of PER and TIM";s:12:"R-DME-432501";s:54:"Transcription repression by PER and activation by PDP1";s:12:"R-DME-432524";s:18:"Degradation of PER";s:12:"R-DME-432553";s:30:"Phosphorylation of PER and TIM";s:12:"R-DME-432560";s:57:"Transcription activation by CLK:CYC and repression by VRI";s:12:"R-DME-432620";s:24:"Dephosphorylation of PER";s:12:"R-DME-432626";s:23:"Circadian Clock pathway";s:12:"R-DME-450724";s:14:"JNK signalling";s:12:"R-DME-450728";s:34:"Inhibition of actin polymerisation";s:12:"R-DME-450736";s:34:"Activation of Downstream Effectors";s:12:"R-DME-450745";s:15:"RAC1 signalling";s:12:"R-DME-450799";s:15:"RHO1 signalling";s:12:"R-DME-451806";s:45:"Phosphorylation-independent inhibition of YKI";s:12:"R-DME-451850";s:32:"Positive regulation of FT and DS";s:12:"R-DME-538848";s:18:"Degradation of CLK";s:12:"R-DME-538864";s:18:"Degradation of CRY";s:12:"R-DME-538898";s:24:"Dephosphorylation of TIM";s:12:"R-DME-538909";s:24:"Dephosphorylation of CLK";s:13:"R-DME-5252538";s:29:"Drosophila signaling pathways";s:11:"R-DME-68616";s:56:"Assembly of the ORC complex at the origin of replication";s:11:"R-DME-68867";s:39:"Assembly of the pre-replicative complex";s:11:"R-DME-69002";s:30:"DNA Replication Pre-Initiation";s:11:"R-DME-68874";s:15:"M/G1 Transition";s:11:"R-DME-69278";s:19:"Cell Cycle, Mitotic";s:13:"R-DME-1640170";s:10:"Cell Cycle";s:11:"R-DME-69306";s:15:"DNA Replication";s:11:"R-DME-69298";s:65:"Association of licensing factors with the pre-replicative complex";s:11:"R-DME-69304";s:29:"Regulation of DNA replication";s:11:"R-DME-68689";s:44:"CDC6 association with the ORC:origin complex";s:11:"R-DME-68827";s:49:"CDT1 association with the CDC6:ORC:origin complex";s:11:"R-DME-68952";s:26:"DNA replication initiation";s:11:"R-DME-69239";s:16:"Synthesis of DNA";s:11:"R-DME-69242";s:7:"S Phase";s:11:"R-DME-68962";s:41:"Activation of the pre-replicative complex";s:11:"R-DME-69206";s:15:"G1/S Transition";s:12:"R-DME-453279";s:22:"Mitotic G1-G1/S phases";s:11:"R-DME-69300";s:41:"Removal of licensing factors from origins";s:11:"R-DME-68949";s:27:"Orc1 removal from chromatin";s:11:"R-DME-69052";s:48:"Switching of origins to a post-replicative state";s:11:"R-DME-69017";s:48:"CDK-mediated phosphorylation and removal of Cdc6";s:11:"R-DME-69091";s:20:"Polymerase switching";s:11:"R-DME-69109";s:24:"Leading Strand Synthesis";s:11:"R-DME-69190";s:21:"DNA strand elongation";s:11:"R-DME-69186";s:24:"Lagging Strand Synthesis";s:11:"R-DME-69183";s:42:"Processive synthesis on the lagging strand";s:11:"R-DME-69166";s:32:"Removal of the Flap Intermediate";s:11:"R-DME-69202";s:50:"Cyclin E associated events during G1/S transition ";s:11:"R-DME-69231";s:32:"Cyclin D associated events in G1";s:11:"R-DME-69236";s:8:"G1 Phase";s:11:"R-DME-69601";s:55:"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A";s:11:"R-DME-69610";s:35:"p53-Independent DNA Damage Response";s:11:"R-DME-69613";s:42:"p53-Independent G1/S DNA damage checkpoint";s:11:"R-DME-69615";s:27:"G1/S DNA Damage Checkpoints";s:11:"R-DME-69620";s:22:"Cell Cycle Checkpoints";s:12:"R-DME-176187";s:51:"Activation of ATR in response to replication stress";s:11:"R-DME-69481";s:16:"G2/M Checkpoints";s:11:"R-DME-70263";s:15:"Gluconeogenesis";s:11:"R-DME-70326";s:18:"Glucose metabolism";s:11:"R-DME-71387";s:27:"Metabolism of carbohydrates";s:13:"R-DME-1430728";s:10:"Metabolism";s:11:"R-DME-70171";s:10:"Glycolysis";s:13:"R-DME-3322077";s:18:"Glycogen synthesis";s:13:"R-DME-8982491";s:19:"Glycogen metabolism";s:12:"R-DME-173599";s:49:"Formation of the active cofactor, UDP-glucuronate";s:12:"R-DME-156588";s:15:"Glucuronidation";s:12:"R-DME-156580";s:35:"Phase II - Conjugation of compounds";s:12:"R-DME-211859";s:21:"Biological oxidations";s:11:"R-DME-70350";s:19:"Fructose catabolism";s:13:"R-DME-5652084";s:19:"Fructose metabolism";s:11:"R-DME-70370";s:20:"Galactose catabolism";s:11:"R-DME-71336";s:54:"Pentose phosphate pathway (hexose monophosphate shunt)";s:13:"R-DME-5628897";s:30:"TP53 Regulates Metabolic Genes";s:13:"R-DME-3700989";s:34:"Transcriptional Regulation by TP53";s:12:"R-DME-212436";s:29:"Generic Transcription Pathway";s:11:"R-DME-73857";s:31:"RNA Polymerase II Transcription";s:11:"R-DME-74160";s:31:"Gene expression (Transcription)";s:11:"R-DME-70221";s:35:"Glycogen breakdown (glycogenolysis)";s:11:"R-DME-70268";s:19:"Pyruvate metabolism";s:11:"R-DME-71406";s:47:"Pyruvate metabolism and Citric Acid (TCA) cycle";s:13:"R-DME-1428517";s:62:"The citric acid (TCA) cycle and respiratory electron transport";s:11:"R-DME-70614";s:57:"Amino acid synthesis and interconversion (transamination)";s:11:"R-DME-71291";s:41:"Metabolism of amino acids and derivatives";s:11:"R-DME-70635";s:10:"Urea cycle";s:12:"R-DME-351202";s:24:"Metabolism of polyamines";s:12:"R-DME-210455";s:52:"Astrocytic Glutamate-Glutamine Uptake And Metabolism";s:12:"R-DME-112313";s:53:"Neurotransmitter uptake and metabolism In glial cells";s:12:"R-DME-112315";s:37:"Transmission across Chemical Synapses";s:12:"R-DME-112316";s:15:"Neuronal System";s:12:"R-DME-210500";s:40:"Glutamate Neurotransmitter Release Cycle";s:12:"R-DME-112310";s:30:"Neurotransmitter release cycle";s:11:"R-DME-70688";s:18:"Proline catabolism";s:13:"R-DME-6788656";s:77:"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism";s:11:"R-DME-70895";s:36:"Branched-chain amino acid catabolism";s:11:"R-DME-71064";s:17:"Lysine catabolism";s:11:"R-DME-71403";s:29:"Citric acid cycle (TCA cycle)";s:11:"R-DME-71182";s:37:"Phenylalanine and tyrosine catabolism";s:11:"R-DME-71240";s:21:"Tryptophan catabolism";s:11:"R-DME-71262";s:19:"Carnitine synthesis";s:11:"R-DME-71384";s:17:"Ethanol oxidation";s:12:"R-DME-211945";s:40:"Phase I - Functionalization of compounds";s:11:"R-DME-72203";s:47:"Processing of Capped Intron-Containing Pre-mRNA";s:13:"R-DME-8953854";s:17:"Metabolism of RNA";s:11:"R-DME-72163";s:29:"mRNA Splicing - Major Pathway";s:11:"R-DME-72172";s:13:"mRNA Splicing";s:11:"R-DME-72187";s:22:"mRNA 3'-end processing";s:12:"R-DME-109688";s:57:"Cleavage of Growing Transcript in the Termination Region ";s:11:"R-DME-73856";s:43:"RNA Polymerase II Transcription Termination";s:11:"R-DME-72702";s:46:"Ribosomal scanning and start codon recognition";s:11:"R-DME-72737";s:36:"Cap-dependent Translation Initiation";s:11:"R-DME-72613";s:33:"Eukaryotic Translation Initiation";s:11:"R-DME-72766";s:11:"Translation";s:12:"R-DME-392499";s:22:"Metabolism of proteins";s:11:"R-DME-72662";s:102:"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S";s:11:"R-DME-72695";s:67:"Formation of the ternary complex, and subsequently, the 43S complex";s:11:"R-DME-72731";s:21:"Recycling of eIF2:GDP";s:11:"R-DME-72706";s:55:"GTP hydrolysis and joining of the 60S ribosomal subunit";s:11:"R-DME-72689";s:40:"Formation of a pool of free 40S subunits";s:12:"R-DME-499943";s:51:"Interconversion of nucleotide di- and triphosphates";s:11:"R-DME-15869";s:25:"Metabolism of nucleotides";s:12:"R-DME-500753";s:23:"Pyrimidine biosynthesis";s:13:"R-DME-8956320";s:23:"Nucleobase biosynthesis";s:11:"R-DME-73843";s:42:"5-Phosphoribose 1-diphosphate biosynthesis";s:11:"R-DME-73621";s:21:"Pyrimidine catabolism";s:13:"R-DME-8956319";s:21:"Nucleobase catabolism";s:11:"R-DME-73614";s:18:"Pyrimidine salvage";s:13:"R-DME-8956321";s:18:"Nucleotide salvage";s:11:"R-DME-73762";s:41:"RNA Polymerase I Transcription Initiation";s:11:"R-DME-73854";s:35:"RNA Polymerase I Promoter Clearance";s:11:"R-DME-73864";s:30:"RNA Polymerase I Transcription";s:11:"R-DME-73772";s:32:"RNA Polymerase I Promoter Escape";s:11:"R-DME-73817";s:48:"Purine ribonucleoside monophosphate biosynthesis";s:11:"R-DME-77111";s:26:"Synthesis of Ketone Bodies";s:11:"R-DME-74182";s:22:"Ketone body metabolism";s:12:"R-DME-556833";s:20:"Metabolism of lipids";s:11:"R-DME-77108";s:28:"Utilization of Ketone Bodies";s:12:"R-DME-674695";s:42:"RNA Polymerase II Pre-transcription Events";s:13:"R-DME-2514859";s:70:"Inactivation, recovery and regulation of the phototransduction cascade";s:13:"R-DME-2514856";s:29:"The phototransduction cascade";s:13:"R-DME-2187338";s:24:"Visual phototransduction";s:12:"R-DME-418594";s:29:"G alpha (i) signalling events";s:12:"R-DME-388396";s:26:"GPCR downstream signalling";s:12:"R-DME-372790";s:17:"Signaling by GPCR";s:12:"R-DME-162582";s:19:"Signal Transduction";s:13:"R-DME-2453902";s:54:"The canonical retinoid cycle in rods (twilight vision)";s:13:"R-DME-2485179";s:43:"Activation of the phototransduction cascade";s:11:"R-DME-74217";s:14:"Purine salvage";s:11:"R-DME-74259";s:17:"Purine catabolism";s:11:"R-DME-77387";s:26:"Insulin receptor recycling";s:11:"R-DME-74752";s:29:"Signaling by Insulin receptor";s:13:"R-DME-9006934";s:38:"Signaling by Receptor Tyrosine Kinases";s:12:"R-DME-112412";s:23:"SOS-mediated signalling";s:12:"R-DME-112399";s:23:"IRS-mediated signalling";s:11:"R-DME-74751";s:35:"Insulin receptor signalling cascade";s:13:"R-DME-2428928";s:37:"IRS-related events triggered by IGF1R";s:13:"R-DME-2428924";s:23:"IGF1R signaling cascade";s:13:"R-DME-2404192";s:65:"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)";s:12:"R-DME-109704";s:12:"PI3K Cascade";s:11:"R-DME-73777";s:33:"RNA Polymerase I Chain Elongation";s:11:"R-DME-75035";s:62:"Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex";s:11:"R-DME-69473";s:26:"G2/M DNA damage checkpoint";s:13:"R-DME-5625740";s:25:"RHO GTPases activate PKNs";s:12:"R-DME-195258";s:20:"RHO GTPase Effectors";s:12:"R-DME-194315";s:24:"Signaling by Rho GTPases";s:11:"R-DME-72165";s:29:"mRNA Splicing - Minor Pathway";s:11:"R-DME-73779";s:67:"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening";s:12:"R-DME-159236";s:69:"Transport of Mature mRNA derived from an Intron-Containing Transcript";s:11:"R-DME-72202";s:43:"Transport of Mature Transcript to Cytoplasm";s:13:"R-DME-5693548";s:35:"Sensing of DNA Double Strand Breaks";s:13:"R-DME-5693606";s:32:"DNA Double Strand Break Response";s:13:"R-DME-5693532";s:30:"DNA Double-Strand Break Repair";s:11:"R-DME-73894";s:10:"DNA Repair";s:11:"R-DME-69229";s:44:"Ubiquitin-dependent degradation of Cyclin D1";s:11:"R-DME-75815";s:43:"Ubiquitin-dependent degradation of Cyclin D";s:11:"R-DME-75105";s:27:"Fatty acyl-CoA biosynthesis";s:13:"R-DME-8978868";s:21:"Fatty acid metabolism";s:11:"R-DME-73776";s:33:"RNA Polymerase II Promoter Escape";s:11:"R-DME-76042";s:65:"RNA Polymerase II Transcription Initiation And Promoter Clearance";s:12:"R-DME-200425";s:53:"Import of palmitoyl-CoA into the mitochondrial matrix";s:11:"R-DME-75953";s:42:"RNA Polymerase II Transcription Initiation";s:11:"R-DME-75896";s:24:"Plasmalogen biosynthesis";s:13:"R-DME-1483166";s:15:"Synthesis of PA";s:13:"R-DME-1483206";s:32:"Glycerophospholipid biosynthesis";s:13:"R-DME-1483257";s:23:"Phospholipid metabolism";s:11:"R-DME-75109";s:25:"Triglyceride biosynthesis";s:13:"R-DME-8979227";s:23:"Triglyceride metabolism";s:13:"R-DME-3299685";s:41:"Detoxification of Reactive Oxygen Species";s:13:"R-DME-2262752";s:28:"Cellular responses to stress";s:13:"R-DME-8953897";s:38:"Cellular responses to external stimuli";s:11:"R-DME-76061";s:64:"RNA Polymerase III Transcription Initiation From Type 1 Promoter";s:11:"R-DME-76046";s:43:"RNA Polymerase III Transcription Initiation";s:11:"R-DME-74158";s:32:"RNA Polymerase III Transcription";s:12:"R-DME-211957";s:64:"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2";s:12:"R-DME-211981";s:11:"Xenobiotics";s:12:"R-DME-211897";s:44:"Cytochrome P450 - arranged by substrate type";s:12:"R-DME-156581";s:11:"Methylation";s:12:"R-DME-211935";s:11:"Fatty acids";s:11:"R-DME-72086";s:12:"mRNA Capping";s:11:"R-DME-77075";s:54:"RNA Pol II CTD phosphorylation and interaction with CE";s:11:"R-DME-77310";s:49:"Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA";s:11:"R-DME-77286";s:64:"mitochondrial fatty acid beta-oxidation of saturated fatty acids";s:11:"R-DME-77289";s:39:"Mitochondrial Fatty Acid Beta-Oxidation";s:11:"R-DME-77285";s:46:"Beta oxidation of myristoyl-CoA to lauroyl-CoA";s:11:"R-DME-77305";s:48:"Beta oxidation of palmitoyl-CoA to myristoyl-CoA";s:11:"R-DME-77352";s:44:"Beta oxidation of butanoyl-CoA to acetyl-CoA";s:11:"R-DME-77350";s:46:"Beta oxidation of hexanoyl-CoA to butanoyl-CoA";s:11:"R-DME-77348";s:46:"Beta oxidation of octanoyl-CoA to hexanoyl-CoA";s:11:"R-DME-77346";s:50:"Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA";s:11:"R-DME-77588";s:68:"SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs";s:11:"R-DME-75067";s:40:"Processing of Capped Intronless Pre-mRNA";s:11:"R-DME-77595";s:34:"Processing of Intronless Pre-mRNAs";s:11:"R-DME-75094";s:26:"Formation of the Editosome";s:11:"R-DME-72200";s:31:"mRNA Editing: C to U Conversion";s:11:"R-DME-75072";s:12:"mRNA Editing";s:11:"R-DME-77042";s:40:"Formation of editosomes by ADAR proteins";s:11:"R-DME-75064";s:31:"mRNA Editing: A to I Conversion";s:11:"R-DME-75102";s:27:"C6 deamination of adenosine";s:11:"R-DME-77288";s:66:"mitochondrial fatty acid beta-oxidation of unsaturated fatty acids";s:11:"R-DME-83936";s:88:"Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane";s:12:"R-DME-425397";s:57:"Transport of vitamins, nucleosides, and related molecules";s:12:"R-DME-425407";s:36:"SLC-mediated transmembrane transport";s:12:"R-DME-382551";s:28:"Transport of small molecules";s:12:"R-DME-165158";s:18:"Activation of AKT2";s:12:"R-DME-179812";s:29:"GRB2 events in EGFR signaling";s:12:"R-DME-177929";s:17:"Signaling by EGFR";s:11:"R-DME-74749";s:18:"Signal attenuation";s:12:"R-DME-112411";s:23:"MAPK1 (ERK2) activation";s:12:"R-DME-112409";s:34:"RAF-independent MAPK1/3 activation";s:13:"R-DME-5684996";s:21:"MAPK1/MAPK3 signaling";s:13:"R-DME-5683057";s:30:"MAPK family signaling cascades";s:12:"R-DME-445144";s:25:"Signal transduction by L1";s:12:"R-DME-373760";s:18:"L1CAM interactions";s:12:"R-DME-422475";s:13:"Axon guidance";s:13:"R-DME-1266738";s:21:"Developmental Biology";s:13:"R-DME-5696395";s:39:"Formation of Incision Complex in GG-NER";s:13:"R-DME-5696399";s:49:"Global Genome Nucleotide Excision Repair (GG-NER)";s:13:"R-DME-5696398";s:26:"Nucleotide Excision Repair";s:12:"R-DME-110329";s:35:"Cleavage of the damaged pyrimidine ";s:11:"R-DME-73928";s:16:"Depyrimidination";s:11:"R-DME-73929";s:39:"Base-Excision Repair, AP Site Formation";s:11:"R-DME-73884";s:20:"Base Excision Repair";s:12:"R-DME-110331";s:30:"Cleavage of the damaged purine";s:11:"R-DME-73927";s:12:"Depurination";s:12:"R-DME-110312";s:29:"Translesion synthesis by REV1";s:12:"R-DME-110313";s:82:"Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template";s:11:"R-DME-73893";s:17:"DNA Damage Bypass";s:12:"R-DME-110320";s:29:"Translesion Synthesis by POLH";s:12:"R-DME-110357";s:40:"Displacement of DNA glycosylase by APEX1";s:11:"R-DME-73933";s:37:"Resolution of Abasic Sites (AP sites)";s:13:"R-DME-5651801";s:46:"PCNA-Dependent Long Patch Base Excision Repair";s:12:"R-DME-110373";s:76:"Resolution of AP sites via the multiple-nucleotide patch replacement pathway";s:12:"R-DME-112043";s:24:"PLC beta mediated events";s:12:"R-DME-112040";s:25:"G-protein mediated events";s:12:"R-DME-111885";s:17:"Opioid Signalling";s:12:"R-DME-163615";s:14:"PKA activation";s:12:"R-DME-111931";s:36:"PKA-mediated phosphorylation of CREB";s:12:"R-DME-111933";s:25:"Calmodulin induced events";s:12:"R-DME-111997";s:11:"CaM pathway";s:12:"R-DME-111996";s:19:"Ca-dependent events";s:13:"R-DME-1489509";s:21:"DAG and IP3 signaling";s:13:"R-DME-9006925";s:44:"Intracellular signaling by second messengers";s:12:"R-DME-164378";s:37:"PKA activation in glucagon signalling";s:12:"R-DME-163359";s:42:"Glucagon signaling in metabolic regulation";s:12:"R-DME-163685";s:32:"Integration of energy metabolism";s:12:"R-DME-180024";s:15:"DARPP-32 events";s:12:"R-DME-432040";s:60:"Vasopressin regulates renal water homeostasis via Aquaporins";s:12:"R-DME-445717";s:28:"Aquaporin-mediated transport";s:12:"R-DME-111957";s:20:"Cam-PDE 1 activation";s:12:"R-DME-112382";s:43:"Formation of RNA Pol II elongation complex ";s:11:"R-DME-75955";s:42:"RNA Polymerase II Transcription Elongation";s:12:"R-DME-113418";s:41:"Formation of the Early Elongation Complex";s:12:"R-DME-113501";s:63:"Inhibition of replication initiation of damaged DNA by RB1/E2F1";s:12:"R-DME-113510";s:42:"E2F mediated regulation of DNA replication";s:12:"R-DME-111459";s:59:"Activation of caspases through apoptosome-mediated cleavage";s:12:"R-DME-111461";s:40:"Cytochrome c-mediated apoptotic response";s:12:"R-DME-111471";s:34:"Apoptotic factor-mediated response";s:12:"R-DME-109606";s:31:"Intrinsic Pathway for Apoptosis";s:12:"R-DME-109581";s:9:"Apoptosis";s:13:"R-DME-5357801";s:21:"Programmed Cell Death";s:12:"R-DME-111458";s:23:"Formation of apoptosome";s:12:"R-DME-111457";s:50:"Release of apoptotic factors from the mitochondria";s:12:"R-DME-416482";s:33:"G alpha (12/13) signalling events";s:11:"R-DME-76005";s:44:"Response to elevated platelet cytosolic Ca2+";s:11:"R-DME-76002";s:46:"Platelet activation, signaling and aggregation";s:12:"R-DME-109582";s:10:"Hemostasis";s:12:"R-DME-416476";s:29:"G alpha (q) signalling events";s:12:"R-DME-114604";s:32:"GPVI-mediated activation cascade";s:12:"R-DME-114508";s:26:"Effects of PIP2 hydrolysis";s:12:"R-DME-139853";s:34:"Elevation of cytosolic Ca2+ levels";s:12:"R-DME-418360";s:28:"Platelet calcium homeostasis";s:12:"R-DME-418346";s:20:"Platelet homeostasis";s:13:"R-DME-5578775";s:15:"Ion homeostasis";s:13:"R-DME-5576891";s:18:"Cardiac conduction";s:12:"R-DME-397014";s:18:"Muscle contraction";s:12:"R-DME-217271";s:25:"FMO oxidises nucleophiles";s:12:"R-DME-140875";s:39:"Common Pathway of Fibrin Clot Formation";s:12:"R-DME-140877";s:43:"Formation of Fibrin Clot (Clotting Cascade)";s:12:"R-DME-141334";s:33:"PAOs oxidise polyamines to amines";s:12:"R-DME-140179";s:23:"Amine Oxidase reactions";s:12:"R-DME-351200";s:29:"Interconversion of polyamines";s:12:"R-DME-141430";s:64:"Inactivation of APC/C via direct inhibition of the APC/C complex";s:12:"R-DME-141405";s:123:"Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components";s:11:"R-DME-69618";s:26:"Mitotic Spindle Checkpoint";s:12:"R-DME-176408";s:62:"Regulation of APC/C activators between G1/S and early anaphase";s:12:"R-DME-174143";s:49:"APC/C-mediated degradation of cell cycle proteins";s:12:"R-DME-453276";s:32:"Regulation of mitotic cell cycle";s:13:"R-DME-5423646";s:39:"Aflatoxin activation and detoxification";s:11:"R-DME-68884";s:29:"Mitotic Telophase/Cytokinesis";s:11:"R-DME-68886";s:7:"M Phase";s:12:"R-DME-156711";s:32:"Polo-like kinase mediated events";s:11:"R-DME-69275";s:15:"G2/M Transition";s:12:"R-DME-453274";s:22:"Mitotic G2-G2/M phases";s:12:"R-DME-156827";s:65:"L13a-mediated translational silencing of Ceruloplasmin expression";s:12:"R-DME-156902";s:24:"Peptide chain elongation";s:12:"R-DME-156842";s:33:"Eukaryotic Translation Elongation";s:13:"R-DME-1980150";s:19:"Signaling by NOTCH4";s:12:"R-DME-157118";s:18:"Signaling by NOTCH";s:12:"R-DME-157212";s:42:"A third proteolytic cleavage releases NICD";s:12:"R-DME-156988";s:83:"Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor";s:11:"R-DME-72649";s:40:"Translation initiation complex formation";s:12:"R-DME-140837";s:42:"Intrinsic Pathway of Fibrin Clot Formation";s:13:"R-DME-6806664";s:23:"Metabolism of vitamin K";s:13:"R-DME-6806667";s:34:"Metabolism of fat-soluble vitamins";s:12:"R-DME-196854";s:36:"Metabolism of vitamins and cofactors";s:12:"R-DME-162710";s:47:"Synthesis of glycosylphosphatidylinositol (GPI)";s:12:"R-DME-163125";s:67:"Post-translational modification: synthesis of GPI-anchored proteins";s:12:"R-DME-597592";s:39:"Post-translational protein modification";s:12:"R-DME-422356";s:31:"Regulation of insulin secretion";s:12:"R-DME-611105";s:30:"Respiratory electron transport";s:12:"R-DME-163200";s:115:"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.";s:12:"R-DME-163282";s:38:"Mitochondrial transcription initiation";s:11:"R-DME-75944";s:42:"Transcription from mitochondrial promoters";s:12:"R-DME-418555";s:29:"G alpha (s) signalling events";s:12:"R-DME-163680";s:56:"AMPK inhibits chREBP transcriptional activation activity";s:12:"R-DME-163358";s:53:"PKA-mediated phosphorylation of key metabolic factors";s:12:"R-DME-163765";s:42:"ChREBP activates metabolic gene expression";s:12:"R-DME-163754";s:59:"Insulin effects increased synthesis of Xylulose-5-Phosphate";s:12:"R-DME-163210";s:41:"Formation of ATP by chemiosmotic coupling";s:12:"R-DME-165181";s:42:"Inhibition of TSC complex formation by PKB";s:12:"R-DME-165159";s:15:"mTOR signalling";s:12:"R-DME-166208";s:26:"mTORC1-mediated signalling";s:12:"R-DME-167826";s:28:"The fatty acid cycling model";s:12:"R-DME-166187";s:33:"Mitochondrial Uncoupling Proteins";s:12:"R-DME-202040";s:20:"G-protein activation";s:12:"R-DME-168181";s:39:"Toll Like Receptor 7/8 (TLR7/8) Cascade";s:12:"R-DME-168898";s:28:"Toll-Like Receptors Cascades";s:12:"R-DME-168249";s:20:"Innate Immune System";s:12:"R-DME-168256";s:13:"Immune System";s:12:"R-DME-450341";s:54:"Activation of the AP-1 family of transcription factors";s:12:"R-DME-450282";s:52:"MAPK targets/ Nuclear events mediated by MAP kinases";s:12:"R-DME-450294";s:36:"MAP kinase activation in TLR cascade";s:12:"R-DME-166058";s:46:"MyD88:Mal cascade initiated on plasma membrane";s:12:"R-DME-166016";s:35:"Toll Like Receptor 4 (TLR4) Cascade";s:12:"R-DME-168179";s:36:"Toll Like Receptor TLR1:TLR2 Cascade";s:12:"R-DME-181438";s:35:"Toll Like Receptor 2 (TLR2) Cascade";s:12:"R-DME-168188";s:36:"Toll Like Receptor TLR6:TLR2 Cascade";s:12:"R-DME-168164";s:35:"Toll Like Receptor 3 (TLR3) Cascade";s:12:"R-DME-448424";s:24:"Interleukin-17 signaling";s:12:"R-DME-449147";s:25:"Signaling by Interleukins";s:13:"R-DME-1280215";s:35:"Cytokine Signaling in Immune system";s:12:"R-DME-937061";s:37:"TRIF(TICAM1)-mediated TLR4 signaling ";s:12:"R-DME-166166";s:31:"MyD88-independent TLR4 cascade ";s:12:"R-DME-975138";s:76:"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation";s:12:"R-DME-975155";s:45:"MyD88 dependent cascade initiated on endosome";s:12:"R-DME-168138";s:35:"Toll Like Receptor 9 (TLR9) Cascade";s:12:"R-DME-975871";s:42:"MyD88 cascade initiated on plasma membrane";s:12:"R-DME-168142";s:37:"Toll Like Receptor 10 (TLR10) Cascade";s:12:"R-DME-168176";s:35:"Toll Like Receptor 5 (TLR5) Cascade";s:13:"R-DME-2559580";s:35:"Oxidative Stress Induced Senescence";s:13:"R-DME-2559583";s:19:"Cellular Senescence";s:13:"R-DME-2871796";s:30:"FCERI mediated MAPK activation";s:13:"R-DME-2454202";s:37:"Fc epsilon receptor (FCERI) signaling";s:12:"R-DME-450321";s:84:"JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1";s:12:"R-DME-445989";s:69:"TAK1 activates NFkB by phosphorylation and activation of IKKs complex";s:13:"R-DME-9020702";s:23:"Interleukin-1 signaling";s:12:"R-DME-446652";s:30:"Interleukin-1 family signaling";s:12:"R-DME-933542";s:31:"TRAF6 mediated NF-kB activation";s:12:"R-DME-168928";s:55:"DDX58/IFIH1-mediated induction of interferon-alpha/beta";s:13:"R-DME-1810476";s:37:"RIP-mediated NFkB activation via ZBP1";s:13:"R-DME-1606322";s:43:"ZBP1(DAI) mediated induction of type I IFNs";s:13:"R-DME-1834949";s:45:"Cytosolic sensors of pathogen-associated DNA ";s:13:"R-DME-3134963";s:78:"DEx/H-box helicases activate type I IFN and inflammatory cytokines production ";s:12:"R-DME-167827";s:26:"The proton buffering model";s:11:"R-DME-69273";s:55:"Cyclin A/B1/B2 associated events during G2/M transition";s:11:"R-DME-69478";s:31:"G2/M DNA replication checkpoint";s:12:"R-DME-170822";s:59:"Regulation of Glucokinase by Glucokinase Regulatory Protein";s:13:"R-DME-2173789";s:43:"TGF-beta receptor signaling activates SMADs";s:12:"R-DME-170834";s:38:"Signaling by TGF-beta Receptor Complex";s:13:"R-DME-9006936";s:36:"Signaling by TGF-beta family members";s:13:"R-DME-1181150";s:18:"Signaling by NODAL";s:13:"R-DME-1502540";s:20:"Signaling by Activin";s:13:"R-DME-2173796";s:54:"SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription";s:13:"R-DME-2173793";s:58:"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer";s:12:"R-DME-171007";s:14:"p38MAPK events";s:12:"R-DME-167044";s:17:"Signalling to RAS";s:12:"R-DME-187687";s:18:"Signalling to ERKs";s:12:"R-DME-187037";s:48:"NGF signalling via TRKA from the plasma membrane";s:12:"R-DME-166520";s:17:"Signalling by NGF";s:13:"R-DME-8964038";s:13:"LDL clearance";s:13:"R-DME-8964043";s:28:"Plasma lipoprotein clearance";s:12:"R-DME-174824";s:54:"Plasma lipoprotein assembly, remodeling, and clearance";s:13:"R-DME-2173795";s:56:"Downregulation of SMAD2/3:SMAD4 transcriptional activity";s:13:"R-DME-2173788";s:45:"Downregulation of TGF-beta receptor signaling";s:12:"R-DME-173736";s:33:"Alternative complement activation";s:12:"R-DME-166663";s:32:"Initial triggering of complement";s:12:"R-DME-166658";s:18:"Complement cascade";s:11:"R-DME-69656";s:48:"Cyclin A:Cdk2-associated events at S phase entry";s:12:"R-DME-174084";s:37:"Autodegradation of Cdh1 by Cdh1:APC/C";s:12:"R-DME-176407";s:58:"Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase";s:12:"R-DME-174178";s:104:"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1";s:12:"R-DME-174184";s:52:"Cdc20:Phospho-APC/C mediated degradation of Cyclin A";s:12:"R-DME-179419";s:103:"APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint";s:12:"R-DME-176409";s:52:"APC/C:Cdc20 mediated degradation of mitotic proteins";s:12:"R-DME-176814";s:76:"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins";s:12:"R-DME-176412";s:28:"Phosphorylation of the APC/C";s:12:"R-DME-174048";s:44:"APC/C:Cdc20 mediated degradation of Cyclin B";s:12:"R-DME-174113";s:42:"SCF-beta-TrCP mediated degradation of Emi1";s:12:"R-DME-174403";s:35:"Glutathione synthesis and recycling";s:12:"R-DME-156590";s:23:"Glutathione conjugation";s:12:"R-DME-727802";s:30:"Transport of nucleotide sugars";s:12:"R-DME-174362";s:31:"Transport and synthesis of PAPS";s:12:"R-DME-156584";s:40:"Cytosolic sulfonation of small molecules";s:13:"R-DME-1630316";s:28:"Glycosaminoglycan metabolism";s:12:"R-DME-174430";s:38:"Telomere C-strand synthesis initiation";s:12:"R-DME-174417";s:44:"Telomere C-strand (Lagging Strand) Synthesis";s:12:"R-DME-180786";s:22:"Extension of Telomeres";s:12:"R-DME-157579";s:20:"Telomere Maintenance";s:11:"R-DME-73886";s:22:"Chromosome Maintenance";s:12:"R-DME-174411";s:52:"Polymerase switching on the C-strand of the telomere";s:13:"R-DME-8963888";s:20:"Chylomicron assembly";s:13:"R-DME-8963898";s:27:"Plasma lipoprotein assembly";s:12:"R-DME-176974";s:16:"Unwinding of DNA";s:12:"R-DME-177504";s:34:"Retrograde neurotrophin signalling";s:12:"R-DME-180292";s:16:"GAB1 signalosome";s:13:"R-DME-5654689";s:19:"PI-3K cascade:FGFR1";s:13:"R-DME-5654687";s:39:"Downstream signaling of activated FGFR1";s:13:"R-DME-5654736";s:18:"Signaling by FGFR1";s:12:"R-DME-190236";s:17:"Signaling by FGFR";s:13:"R-DME-5654695";s:19:"PI-3K cascade:FGFR2";s:13:"R-DME-5654696";s:39:"Downstream signaling of activated FGFR2";s:13:"R-DME-5654738";s:18:"Signaling by FGFR2";s:13:"R-DME-5654710";s:19:"PI-3K cascade:FGFR3";s:13:"R-DME-5654708";s:39:"Downstream signaling of activated FGFR3";s:13:"R-DME-5654741";s:18:"Signaling by FGFR3";s:13:"R-DME-5654720";s:19:"PI-3K cascade:FGFR4";s:13:"R-DME-5654716";s:39:"Downstream signaling of activated FGFR4";s:13:"R-DME-5654743";s:18:"Signaling by FGFR4";s:12:"R-DME-180336";s:29:"SHC1 events in EGFR signaling";s:12:"R-DME-179409";s:39:"APC-Cdc20 mediated degradation of Nek2A";s:12:"R-DME-182971";s:19:"EGFR downregulation";s:12:"R-DME-187577";s:41:"SCF(Skp2)-mediated degradation of p27/p21";s:13:"R-DME-4420097";s:20:"VEGFA-VEGFR2 Pathway";s:12:"R-DME-194138";s:17:"Signaling by VEGF";s:11:"R-DME-68911";s:8:"G2 Phase";s:11:"R-DME-69200";s:89:"Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes";s:12:"R-DME-163560";s:23:"Triglyceride catabolism";s:12:"R-DME-189085";s:33:"Digestion of dietary carbohydrate";s:13:"R-DME-8935690";s:9:"Digestion";s:13:"R-DME-8963743";s:24:"Digestion and absorption";s:12:"R-DME-189200";s:25:"Cellular hexose transport";s:13:"R-DME-8981373";s:28:"Intestinal hexose absorption";s:13:"R-DME-8963676";s:21:"Intestinal absorption";s:12:"R-DME-189483";s:16:"Heme degradation";s:12:"R-DME-189445";s:24:"Metabolism of porphyrins";s:12:"R-DME-917937";s:25:"Iron uptake and transport";s:12:"R-DME-189451";s:17:"Heme biosynthesis";s:12:"R-DME-190370";s:36:"FGFR1b ligand binding and activation";s:12:"R-DME-190242";s:35:"FGFR1 ligand binding and activation";s:12:"R-DME-190373";s:36:"FGFR1c ligand binding and activation";s:12:"R-DME-190375";s:36:"FGFR2c ligand binding and activation";s:12:"R-DME-190241";s:35:"FGFR2 ligand binding and activation";s:12:"R-DME-190377";s:36:"FGFR2b ligand binding and activation";s:12:"R-DME-190372";s:36:"FGFR3c ligand binding and activation";s:12:"R-DME-190239";s:35:"FGFR3 ligand binding and activation";s:12:"R-DME-190371";s:36:"FGFR3b ligand binding and activation";s:12:"R-DME-190322";s:35:"FGFR4 ligand binding and activation";s:12:"R-DME-191273";s:24:"Cholesterol biosynthesis";s:13:"R-DME-8957322";s:22:"Metabolism of steroids";s:12:"R-DME-446199";s:31:"Synthesis of Dolichyl-phosphate";s:12:"R-DME-446219";s:47:"Synthesis of substrates in N-glycan biosythesis";s:12:"R-DME-446193";s:117:"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein";s:12:"R-DME-446203";s:33:"Asparagine N-linked glycosylation";s:12:"R-DME-191859";s:14:"snRNP Assembly";s:12:"R-DME-194441";s:28:"Metabolism of non-coding RNA";s:12:"R-DME-193368";s:68:"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol";s:12:"R-DME-192105";s:38:"Synthesis of bile acids and bile salts";s:12:"R-DME-194068";s:34:"Bile acid and bile salt metabolism";s:12:"R-DME-193807";s:64:"Synthesis of bile acids and bile salts via 27-hydroxycholesterol";s:12:"R-DME-211976";s:18:"Endogenous sterols";s:12:"R-DME-193993";s:30:"Mineralocorticoid biosynthesis";s:12:"R-DME-196071";s:30:"Metabolism of steroid hormones";s:12:"R-DME-209943";s:16:"Steroid hormones";s:12:"R-DME-196108";s:25:"Pregnenolone biosynthesis";s:12:"R-DME-193048";s:21:"Androgen biosynthesis";s:12:"R-DME-194002";s:27:"Glucocorticoid biosynthesis";s:12:"R-DME-159418";s:33:"Recycling of bile acids and salts";s:12:"R-DME-193648";s:31:"NRAGE signals death through JNK";s:12:"R-DME-204998";s:46:"Cell death signalling via NRAGE, NRIF and NADE";s:12:"R-DME-193704";s:36:"p75 NTR receptor-mediated signalling";s:12:"R-DME-209560";s:39:"NF-kB is activated and signals survival";s:12:"R-DME-193639";s:24:"p75NTR signals via NF-kB";s:12:"R-DME-193775";s:64:"Synthesis of bile acids and bile salts via 24-hydroxycholesterol";s:12:"R-DME-193634";s:42:"Axonal growth inhibition (RHOA activation)";s:12:"R-DME-193697";s:29:"p75NTR regulates axonogenesis";s:12:"R-DME-194840";s:16:"Rho GTPase cycle";s:12:"R-DME-195253";s:54:"Degradation of beta-catenin by the destruction complex";s:12:"R-DME-195721";s:16:"Signaling by WNT";s:12:"R-DME-196299";s:36:"Beta-catenin phosphorylation cascade";s:13:"R-DME-6807047";s:40:"Cholesterol biosynthesis via desmosterol";s:12:"R-DME-196783";s:23:"Coenzyme A biosynthesis";s:12:"R-DME-199220";s:36:"Vitamin B5 (pantothenate) metabolism";s:12:"R-DME-196849";s:50:"Metabolism of water-soluble vitamins and cofactors";s:12:"R-DME-196819";s:31:"Vitamin B1 (thiamin) metabolism";s:12:"R-DME-196843";s:34:"Vitamin B2 (riboflavin) metabolism";s:12:"R-DME-197264";s:22:"Nicotinamide salvaging";s:12:"R-DME-196807";s:21:"Nicotinate metabolism";s:12:"R-DME-196757";s:33:"Metabolism of folate and pterines";s:12:"R-DME-198203";s:19:"PI3K/AKT activation";s:12:"R-DME-389357";s:33:"CD28 dependent PI3K/Akt signaling";s:12:"R-DME-389356";s:19:"CD28 co-stimulation";s:12:"R-DME-388841";s:32:"Costimulation by the CD28 family";s:13:"R-DME-1280218";s:22:"Adaptive Immune System";s:13:"R-DME-1257604";s:28:"PIP3 activates AKT signaling";s:13:"R-DME-5218920";s:37:"VEGFR2 mediated vascular permeability";s:12:"R-DME-392451";s:41:"G beta:gamma signalling through PI3Kgamma";s:12:"R-DME-397795";s:31:"G-protein beta:gamma signalling";s:13:"R-DME-2029485";s:37:"Role of phospholipids in phagocytosis";s:13:"R-DME-2029480";s:46:"Fcgamma receptor (FCGR) dependent phagocytosis";s:12:"R-DME-198323";s:41:"AKT phosphorylates targets in the cytosol";s:12:"R-DME-198753";s:16:"ERK/MAPK targets";s:12:"R-DME-198725";s:59:"Nuclear Events (kinase and transcription factor activation)";s:12:"R-DME-881907";s:48:"Gastrin-CREB signalling pathway via PKC and MAPK";s:13:"R-DME-2559582";s:48:"Senescence-Associated Secretory Phenotype (SASP)";s:12:"R-DME-375165";s:37:"NCAM signaling for neurite out-growth";s:12:"R-DME-196836";s:32:"Vitamin C (ascorbate) metabolism";s:12:"R-DME-196780";s:31:"Biotin transport and metabolism";s:12:"R-DME-198693";s:41:"AKT phosphorylates targets in the nucleus";s:12:"R-DME-199418";s:43:"Negative regulation of the PI3K/AKT network";s:12:"R-DME-202424";s:24:"Downstream TCR signaling";s:12:"R-DME-202403";s:13:"TCR signaling";s:13:"R-DME-1660499";s:40:"Synthesis of PIPs at the plasma membrane";s:13:"R-DME-1483255";s:13:"PI Metabolism";s:12:"R-DME-199920";s:20:"CREB phosphorylation";s:11:"R-DME-71288";s:19:"Creatine metabolism";s:13:"R-DME-5362517";s:26:"Signaling by Retinoic Acid";s:13:"R-DME-9006931";s:30:"Signaling by Nuclear Receptors";s:12:"R-DME-380972";s:48:"Energy dependent regulation of mTOR by LKB1-AMPK";s:11:"R-DME-75876";s:44:"Synthesis of very long-chain fatty acyl-CoAs";s:12:"R-DME-201451";s:16:"Signaling by BMP";s:12:"R-DME-111465";s:39:"Apoptotic cleavage of cellular proteins";s:11:"R-DME-75153";s:26:"Apoptotic execution  phase";s:12:"R-DME-264870";s:50:"Caspase-mediated cleavage of cytoskeletal proteins";s:12:"R-DME-201681";s:42:"TCF dependent signaling in response to WNT";s:13:"R-DME-4641262";s:78:"Disassembly of the destruction complex and recruitment of AXIN to the membrane";s:12:"R-DME-203615";s:15:"eNOS activation";s:12:"R-DME-203765";s:30:"eNOS activation and regulation";s:12:"R-DME-202131";s:26:"Metabolism of nitric oxide";s:13:"R-DME-2730905";s:45:"Role of LAT2/NTAL/LAB on calcium mobilization";s:13:"R-DME-2871837";s:31:"FCERI mediated NF-kB activation";s:12:"R-DME-202433";s:40:"Generation of second messenger molecules";s:12:"R-DME-202733";s:46:"Cell surface interactions at the vascular wall";s:13:"R-DME-1566977";s:28:"Fibronectin matrix formation";s:13:"R-DME-1474244";s:33:"Extracellular matrix organization";s:12:"R-DME-351906";s:45:"Apoptotic cleavage of cell adhesion  proteins";s:12:"R-DME-203754";s:31:"NOSIP mediated eNOS trafficking";s:12:"R-DME-203641";s:33:"NOSTRIN mediated eNOS trafficking";s:12:"R-DME-202670";s:20:"ERKs are inactivated";s:12:"R-DME-204174";s:50:"Regulation of pyruvate dehydrogenase (PDH) complex";s:12:"R-DME-204005";s:49:"COPII (Coat Protein 2) Mediated Vesicle Transport";s:12:"R-DME-199977";s:33:"ER to Golgi Anterograde Transport";s:12:"R-DME-199991";s:20:"Membrane Trafficking";s:13:"R-DME-5653656";s:26:"Vesicle-mediated transport";s:12:"R-DME-948021";s:50:"Transport to the Golgi and subsequent modification";s:12:"R-DME-983170";s:74:"Antigen Presentation: Folding, assembly and peptide loading of class I MHC";s:12:"R-DME-983169";s:54:"Class I MHC mediated antigen processing & presentation";s:12:"R-DME-210991";s:20:"Basigin interactions";s:12:"R-DME-216083";s:34:"Integrin cell surface interactions";s:13:"R-DME-1433557";s:20:"Signaling by SCF-KIT";s:13:"R-DME-1433559";s:27:"Regulation of KIT signaling";s:12:"R-DME-196791";s:33:"Vitamin D (calciferol) metabolism";s:12:"R-DME-209968";s:22:"Thyroxine biosynthesis";s:12:"R-DME-209776";s:22:"Amine-derived hormones";s:12:"R-DME-209931";s:36:"Serotonin and melatonin biosynthesis";s:12:"R-DME-209905";s:26:"Catecholamine biosynthesis";s:12:"R-DME-211916";s:8:"Vitamins";s:12:"R-DME-203927";s:27:"MicroRNA (miRNA) biogenesis";s:12:"R-DME-211000";s:21:"Gene Silencing by RNA";s:12:"R-DME-210746";s:80:"Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells";s:12:"R-DME-186712";s:35:"Regulation of beta-cell development";s:12:"R-DME-210993";s:14:"Tie2 Signaling";s:12:"R-DME-211163";s:35:"AKT-mediated inactivation of FOXO1A";s:12:"R-DME-210745";s:43:"Regulation of gene expression in beta cells";s:12:"R-DME-211227";s:38:"Activation of DNA fragmentation factor";s:12:"R-DME-140342";s:35:"Apoptosis induced DNA fragmentation";s:12:"R-DME-211979";s:11:"Eicosanoids";s:13:"R-DME-2142691";s:46:"Synthesis of Leukotrienes (LT) and Eoxins (EX)";s:13:"R-DME-2142753";s:27:"Arachidonic acid metabolism";s:13:"R-DME-5365859";s:23:"RA biosynthesis pathway";s:12:"R-DME-211958";s:24:"Miscellaneous substrates";s:12:"R-DME-212300";s:32:"PRC2 methylates histones and DNA";s:12:"R-DME-212165";s:40:"Epigenetic regulation of gene expression";s:13:"R-DME-3000157";s:20:"Laminin interactions";s:12:"R-DME-264642";s:44:"Acetylcholine Neurotransmitter Release Cycle";s:13:"R-DME-1483191";s:15:"Synthesis of PC";s:13:"R-DME-8964058";s:14:"HDL remodeling";s:13:"R-DME-8963899";s:29:"Plasma lipoprotein remodeling";s:12:"R-DME-352238";s:31:"Breakdown of the nuclear lamina";s:12:"R-DME-264876";s:18:"Insulin processing";s:13:"R-DME-2980736";s:26:"Peptide hormone metabolism";s:13:"R-DME-2162123";s:54:"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)";s:13:"R-DME-1369062";s:37:"ABC transporters in lipid homeostasis";s:12:"R-DME-382556";s:38:"ABC-family proteins mediated transport";s:12:"R-DME-351143";s:21:"Agmatine biosynthesis";s:12:"R-DME-114608";s:23:"Platelet degranulation ";s:12:"R-DME-352230";s:47:"Amino acid transport across the plasma membrane";s:12:"R-DME-425374";s:44:"Amino acid and oligopeptide SLC transporters";s:12:"R-DME-425393";s:67:"Transport of inorganic cations/anions and amino acids/oligopeptides";s:12:"R-DME-442660";s:47:"Na+/Cl- dependent neurotransmitter transporters";s:12:"R-DME-425366";s:73:"Transport of bile salts and organic acids, metal ions and amine compounds";s:12:"R-DME-425428";s:31:"Amine compound SLC transporters";s:12:"R-DME-354192";s:33:"Integrin alphaIIb beta3 signaling";s:11:"R-DME-76009";s:37:"Platelet Aggregation (Plug Formation)";s:13:"R-DME-9006921";s:18:"Integrin signaling";s:12:"R-DME-354194";s:58:"GRB2:SOS provides linkage to MAPK signaling for Integrins ";s:12:"R-DME-112311";s:26:"Neurotransmitter clearance";s:12:"R-DME-181430";s:45:"Norepinephrine Neurotransmitter Release Cycle";s:12:"R-DME-212676";s:39:"Dopamine Neurotransmitter Release Cycle";s:12:"R-DME-372708";s:47:"p130Cas linkage to MAPK signaling for integrins";s:12:"R-DME-428643";s:26:"Organic anion transporters";s:12:"R-DME-420499";s:54:"Class C/3 (Metabotropic glutamate/pheromone receptors)";s:12:"R-DME-500792";s:19:"GPCR ligand binding";s:12:"R-DME-418889";s:45:"Ligand-independent caspase activation via DCC";s:13:"R-DME-5357769";s:61:"Caspase activation via extrinsic apoptotic signalling pathway";s:12:"R-DME-418885";s:33:"DCC mediated attractive signaling";s:12:"R-DME-373752";s:18:"Netrin-1 signaling";s:12:"R-DME-373753";s:27:"Nephrin family interactions";s:13:"R-DME-1500931";s:23:"Cell-Cell communication";s:12:"R-DME-447043";s:24:"Neurofascin interactions";s:12:"R-DME-437239";s:23:"Recycling pathway of L1";s:12:"R-DME-375170";s:17:"CDO in myogenesis";s:12:"R-DME-525793";s:10:"Myogenesis";s:12:"R-DME-419037";s:18:"NCAM1 interactions";s:12:"R-DME-428559";s:46:"Proton-coupled neutral amino acid transporters";s:12:"R-DME-376172";s:18:"DSCAM interactions";s:12:"R-DME-383280";s:38:"Nuclear Receptor transcription pathway";s:12:"R-DME-379401";s:42:"Dopamine clearance from the synaptic cleft";s:12:"R-DME-181429";s:40:"Serotonin Neurotransmitter Release Cycle";s:12:"R-DME-380612";s:23:"Metabolism of serotonin";s:12:"R-DME-380615";s:43:"Serotonin clearance from the synaptic cleft";s:12:"R-DME-381033";s:38:"ATF6 (ATF6-alpha) activates chaperones";s:12:"R-DME-381119";s:31:"Unfolded Protein Response (UPR)";s:12:"R-DME-381042";s:30:"PERK regulates gene expression";s:12:"R-DME-381070";s:30:"IRE1alpha activates chaperones";s:12:"R-DME-381340";s:61:"Transcriptional regulation of white adipocyte differentiation";s:12:"R-DME-381676";s:58:"Glucagon-like Peptide-1 (GLP1) regulates insulin secretion";s:13:"R-DME-1369007";s:30:"Mitochondrial ABC transporters";s:12:"R-DME-388844";s:43:"Receptor-type tyrosine-protein phosphatases";s:13:"R-DME-6794362";s:40:"Protein-protein interactions at synapses";s:12:"R-DME-389542";s:18:"NADPH regeneration";s:13:"R-DME-8978934";s:23:"Metabolism of cofactors";s:12:"R-DME-389599";s:28:"Alpha-oxidation of phytanate";s:12:"R-DME-390918";s:28:"Peroxisomal lipid metabolism";s:12:"R-DME-389661";s:45:"Glyoxylate metabolism and glycine degradation";s:12:"R-DME-389887";s:32:"Beta-oxidation of pristanoyl-CoA";s:12:"R-DME-390247";s:45:"Beta-oxidation of very long chain fatty acids";s:13:"R-DME-8848584";s:16:"Wax biosynthesis";s:12:"R-DME-390648";s:34:"Muscarinic acetylcholine receptors";s:12:"R-DME-375280";s:30:"Amine ligand-binding receptors";s:12:"R-DME-373076";s:36:"Class A/1 (Rhodopsin-like receptors)";s:12:"R-DME-390696";s:13:"Adrenoceptors";s:12:"R-DME-392023";s:57:"Adrenaline signalling through Alpha-2 adrenergic receptor";s:12:"R-DME-390651";s:18:"Dopamine receptors";s:12:"R-DME-390650";s:19:"Histamine receptors";s:12:"R-DME-390666";s:19:"Serotonin receptors";s:12:"R-DME-390471";s:64:"Association of TriC/CCT with target proteins during biosynthesis";s:12:"R-DME-390466";s:35:"Chaperonin-mediated protein folding";s:12:"R-DME-391251";s:15:"Protein folding";s:12:"R-DME-418597";s:29:"G alpha (z) signalling events";s:12:"R-DME-392517";s:15:"Rap1 signalling";s:12:"R-DME-399710";s:28:"Activation of AMPA receptors";s:12:"R-DME-399721";s:71:"Glutamate binding, activation of AMPA receptors and synaptic plasticity";s:12:"R-DME-112314";s:63:"Neurotransmitter receptors and postsynaptic signal transmission";s:12:"R-DME-399955";s:65:"SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion";s:12:"R-DME-373755";s:23:"Semaphorin interactions";s:12:"R-DME-399997";s:41:"Acetylcholine regulates insulin secretion";s:12:"R-DME-434316";s:61:"Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion";s:12:"R-DME-400451";s:43:"Free fatty acids regulate insulin secretion";s:13:"R-DME-2179392";s:31:"EGFR Transactivation by Gastrin";s:12:"R-DME-400042";s:51:"Adrenaline,noradrenaline inhibits insulin secretion";s:12:"R-DME-400206";s:94:"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)";s:12:"R-DME-416572";s:54:"Sema4D induced cell migration and growth-cone collapse";s:12:"R-DME-400685";s:30:"Sema4D in semaphorin signaling";s:12:"R-DME-416993";s:46:"Trafficking of GluR2-containing AMPA receptors";s:12:"R-DME-399719";s:29:"Trafficking of AMPA receptors";s:12:"R-DME-416700";s:29:"Other semaphorin interactions";s:12:"R-DME-456926";s:65:"Thrombin signalling through proteinase activated receptors (PARs)";s:12:"R-DME-418359";s:34:"Reduction of cytosolic Ca++ levels";s:12:"R-DME-936837";s:31:"Ion transport by P-type ATPases";s:12:"R-DME-983712";s:21:"Ion channel transport";s:12:"R-DME-392154";s:41:"Nitric oxide stimulates guanylate cyclase";s:13:"R-DME-1222556";s:33:"ROS, RNS production in phagocytes";s:12:"R-DME-418457";s:12:"cGMP effects";s:12:"R-DME-418592";s:41:"ADP signalling through P2Y purinoceptor 1";s:12:"R-DME-392518";s:20:"Signal amplification";s:12:"R-DME-417973";s:22:"Adenosine P1 receptors";s:12:"R-DME-418038";s:38:"Nucleotide-like (purinergic) receptors";s:13:"R-DME-5683826";s:21:"Surfactant metabolism";s:12:"R-DME-418990";s:31:"Adherens junctions interactions";s:12:"R-DME-421270";s:31:"Cell-cell junction organization";s:12:"R-DME-446728";s:26:"Cell junction organization";s:13:"R-DME-5627117";s:26:"RHO GTPases Activate ROCKs";s:12:"R-DME-399954";s:35:"Sema3A PAK dependent Axon repulsion";s:13:"R-DME-2029482";s:57:"Regulation of actin dynamics for phagocytic cup formation";s:12:"R-DME-419771";s:6:"Opsins";s:12:"R-DME-977444";s:26:"GABA B receptor activation";s:12:"R-DME-977443";s:24:"GABA receptor activation";s:12:"R-DME-432722";s:35:"Golgi Associated Vesicle Biogenesis";s:12:"R-DME-421837";s:32:"Clathrin derived vesicle budding";s:12:"R-DME-199992";s:35:"trans-Golgi Network Vesicle Budding";s:12:"R-DME-425381";s:24:"Bicarbonate transporters";s:12:"R-DME-425561";s:25:"Sodium/Calcium exchangers";s:12:"R-DME-425986";s:24:"Sodium/Proton exchangers";s:12:"R-DME-426048";s:32:"Arachidonate production from DAG";s:12:"R-DME-426117";s:38:"Cation-coupled Chloride cotransporters";s:12:"R-DME-426486";s:40:"Small interfering RNA (siRNA) biogenesis";s:12:"R-DME-426496";s:44:"Post-transcriptional silencing by small RNAs";s:12:"R-DME-427413";s:41:"NoRC negatively regulates rRNA expression";s:13:"R-DME-5250941";s:49:"Negative epigenetic regulation of rRNA expression";s:12:"R-DME-427359";s:42:"SIRT1 negatively regulates rRNA expression";s:12:"R-DME-427601";s:32:"Multifunctional anion exchangers";s:12:"R-DME-427652";s:39:"Sodium-coupled phosphate cotransporters";s:12:"R-DME-427975";s:34:"Proton/oligopeptide cotransporters";s:13:"R-DME-1660661";s:33:"Sphingolipid de novo biosynthesis";s:12:"R-DME-428157";s:23:"Sphingolipid metabolism";s:12:"R-DME-428542";s:59:"Regulation of commissural axon pathfinding by SLIT and ROBO";s:12:"R-DME-376176";s:27:"Signaling by ROBO receptors";s:13:"R-DME-4085001";s:22:"Sialic acid metabolism";s:12:"R-DME-429593";s:21:"Inositol transporters";s:12:"R-DME-430039";s:38:"mRNA decay by 5' to 3' exoribonuclease";s:12:"R-DME-429914";s:34:"Deadenylation-dependent mRNA decay";s:12:"R-DME-429958";s:38:"mRNA decay by 3' to 5' exoribonuclease";s:12:"R-DME-446388";s:82:"Regulation of cytoskeletal remodeling and cell spreading by IPP complex components";s:12:"R-DME-446353";s:38:"Cell-extracellular matrix interactions";s:12:"R-DME-432047";s:31:"Passive transport by Aquaporins";s:12:"R-DME-432142";s:29:"Platelet sensitization by LDL";s:12:"R-DME-432720";s:27:"Lysosome Vesicle Biogenesis";s:12:"R-DME-446343";s:63:"Localization of the PINCH-ILK-PARVIN complex to focal adhesions";s:12:"R-DME-425471";s:44:"Bile salt and organic anion SLC transporters";s:12:"R-DME-433137";s:61:"Sodium-coupled sulphate, di- and tri-carboxylate transporters";s:12:"R-DME-425410";s:26:"Metal ion SLC transporters";s:13:"R-DME-6803544";s:44:"Ion influx/efflux at host-pathogen interface";s:13:"R-DME-6803157";s:22:"Antimicrobial peptides";s:12:"R-DME-435368";s:56:"Zinc efflux and compartmentalization by the SLC30 family";s:12:"R-DME-435354";s:17:"Zinc transporters";s:12:"R-DME-438066";s:61:"Unblocking of NMDA receptor, glutamate binding and activation";s:12:"R-DME-442755";s:51:"Activation of NMDA receptor and postsynaptic events";s:12:"R-DME-442380";s:47:"Zinc influx into cells by the SLC39 gene family";s:12:"R-DME-442720";s:64:"CREB phosphorylation through the activation of Adenylate Cyclase";s:12:"R-DME-438064";s:36:"Post NMDA receptor activation events";s:12:"R-DME-442742";s:50:"CREB phosphorylation through the activation of Ras";s:12:"R-DME-444257";s:14:"RSK activation";s:12:"R-DME-442717";s:52:"CREB phosphorylation through the activation of CaMKK";s:12:"R-DME-430116";s:31:"GP1b-IX-V activation signalling";s:12:"R-DME-888593";s:16:"Reuptake of GABA";s:12:"R-DME-888590";s:49:"GABA synthesis, release, reuptake and degradation";s:12:"R-DME-444411";s:48:"Rhesus glycoproteins mediate ammonium transport.";s:12:"R-DME-373080";s:37:"Class B/2 (Secretin family receptors)";s:12:"R-DME-445355";s:25:"Smooth Muscle Contraction";s:13:"R-DME-5627123";s:25:"RHO GTPases activate PAKs";s:12:"R-DME-446210";s:37:"Synthesis of UDP-N-acetyl-glucosamine";s:12:"R-DME-446205";s:24:"Synthesis of GDP-mannose";s:12:"R-DME-480985";s:39:"Synthesis of dolichyl-phosphate-glucose";s:12:"R-DME-448706";s:24:"Interleukin-1 processing";s:12:"R-DME-449836";s:27:"Other interleukin signaling";s:12:"R-DME-450302";s:43:"activated TAK1 mediates p38 MAPK activation";s:12:"R-DME-450385";s:61:"Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA";s:12:"R-DME-450531";s:67:"Regulation of mRNA stability by proteins that bind AU-rich elements";s:12:"R-DME-450408";s:43:"AUF1 (hnRNP D0) binds and destabilizes mRNA";s:12:"R-DME-450520";s:38:"HuR (ELAVL1) binds and stabilizes mRNA";s:12:"R-DME-450604";s:40:"KSRP (KHSRP) binds and destabilizes mRNA";s:12:"R-DME-451307";s:44:"Activation of Na-permeable kainate receptors";s:12:"R-DME-451306";s:40:"Ionotropic activity of kainate receptors";s:12:"R-DME-451326";s:54:"Activation of kainate receptors upon glutamate binding";s:12:"R-DME-512988";s:37:"Interleukin-3, 5 and GM-CSF signaling";s:12:"R-DME-982772";s:33:"Growth hormone receptor signaling";s:13:"R-DME-1266695";s:23:"Interleukin-7 signaling";s:13:"R-DME-2586552";s:19:"Signaling by Leptin";s:13:"R-DME-9020558";s:23:"Interleukin-2 signaling";s:12:"R-DME-451927";s:30:"Interleukin-2 family signaling";s:12:"R-DME-500657";s:41:"Presynaptic function of Kainate receptors";s:12:"R-DME-532668";s:59:"N-glycan trimming in the ER and Calnexin/Calreticulin cycle";s:12:"R-DME-901042";s:27:"Calnexin/calreticulin cycle";s:12:"R-DME-901032";s:37:"ER Quality Control Compartment (ERQC)";s:12:"R-DME-549127";s:24:"Organic cation transport";s:12:"R-DME-549132";s:41:"Organic cation/anion/zwitterion transport";s:12:"R-DME-629587";s:57:"Highly sodium permeable acetylcholine nicotinic receptors";s:12:"R-DME-622323";s:45:"Presynaptic nicotinic acetylcholine receptors";s:12:"R-DME-629602";s:47:"Activation of Nicotinic Acetylcholine Receptors";s:12:"R-DME-181431";s:43:"Acetylcholine binding and downstream events";s:12:"R-DME-622327";s:46:"Postsynaptic nicotinic acetylcholine receptors";s:12:"R-DME-629597";s:58:"Highly calcium permeable nicotinic acetylcholine receptors";s:12:"R-DME-629594";s:71:"Highly calcium permeable postsynaptic nicotinic acetylcholine receptors";s:13:"R-DME-6787639";s:23:"GDP-fucose biosynthesis";s:13:"R-DME-2022854";s:28:"Keratan sulfate biosynthesis";s:13:"R-DME-1638074";s:34:"Keratan sulfate/keratin metabolism";s:13:"R-DME-2022928";s:19:"HS-GAG biosynthesis";s:13:"R-DME-1638091";s:43:"Heparan sulfate/heparin (HS-GAG) metabolism";s:13:"R-DME-5689880";s:32:"Ub-specific processing proteases";s:13:"R-DME-5688426";s:16:"Deubiquitination";s:12:"R-DME-877300";s:26:"Interferon gamma signaling";s:12:"R-DME-913531";s:20:"Interferon Signaling";s:12:"R-DME-844456";s:22:"The NLRP3 inflammasome";s:12:"R-DME-622312";s:13:"Inflammasomes";s:12:"R-DME-168643";s:91:"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways";s:12:"R-DME-983231";s:69:"Factors involved in megakaryocyte development and platelet production";s:12:"R-DME-879518";s:27:"Transport of organic anions";s:12:"R-DME-804914";s:24:"Transport of fatty acids";s:12:"R-DME-912631";s:30:"Regulation of signaling by CBL";s:12:"R-DME-880009";s:56:"Interconversion of 2-oxoglutarate and 2-hydroxyglutarate";s:12:"R-DME-916853";s:19:"Degradation of GABA";s:12:"R-DME-888568";s:14:"GABA synthesis";s:12:"R-DME-909733";s:31:"Interferon alpha/beta signaling";s:12:"R-DME-913709";s:32:"O-linked glycosylation of mucins";s:13:"R-DME-5173105";s:22:"O-linked glycosylation";s:12:"R-DME-917729";s:56:"Endosomal Sorting Complex Required For Transport (ESCRT)";s:12:"R-DME-917977";s:37:"Transferrin endocytosis and recycling";s:12:"R-DME-975956";s:76:"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)";s:12:"R-DME-927802";s:29:"Nonsense-Mediated Decay (NMD)";s:12:"R-DME-975957";s:73:"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)";s:13:"R-DME-1295596";s:32:"Spry regulation of FGF signaling";s:13:"R-DME-5654726";s:38:"Negative regulation of FGFR1 signaling";s:13:"R-DME-5654727";s:38:"Negative regulation of FGFR2 signaling";s:13:"R-DME-5654732";s:38:"Negative regulation of FGFR3 signaling";s:13:"R-DME-5654733";s:38:"Negative regulation of FGFR4 signaling";s:12:"R-DME-937042";s:41:"IRAK2 mediated activation of TAK1 complex";s:12:"R-DME-937039";s:26:"IRAK1 recruits IKK complex";s:12:"R-DME-947581";s:32:"Molybdenum cofactor biosynthesis";s:12:"R-DME-964827";s:101:"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2";s:12:"R-DME-964739";s:49:"N-glycan trimming and elongation in the cis-Golgi";s:12:"R-DME-964975";s:45:"Vitamins B6 activation to pyridoxal phosphate";s:12:"R-DME-975110";s:55:"TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling";s:12:"R-DME-975144";s:55:"IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation";s:12:"R-DME-975163";s:70:"IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation";s:12:"R-DME-977441";s:26:"GABA A receptor activation";s:12:"R-DME-975634";s:33:"Retinoid metabolism and transport";s:12:"R-DME-975578";s:60:"Reactions specific to the complex N-glycan synthesis pathway";s:12:"R-DME-975576";s:54:"N-glycan antennae elongation in the medial/trans-Golgi";s:12:"R-DME-975577";s:28:"N-Glycan antennae elongation";s:12:"R-DME-975574";s:59:"Reactions specific to the hybrid N-glycan synthesis pathway";s:12:"R-DME-977068";s:36:"Termination of O-glycan biosynthesis";s:11:"R-DME-70921";s:20:"Histidine catabolism";s:12:"R-DME-977347";s:19:"Serine biosynthesis";s:12:"R-DME-983168";s:59:"Antigen processing: Ubiquitination & Proteasome degradation";s:12:"R-DME-983189";s:8:"Kinesins";s:12:"R-DME-877312";s:28:"Regulation of IFNG signaling";s:12:"R-DME-997272";s:67:"Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits";s:12:"R-DME-991365";s:29:"Activation of GABAB receptors";s:13:"R-DME-1296041";s:48:"Activation of G protein gated Potassium channels";s:13:"R-DME-1296059";s:34:"G protein gated Potassium channels";s:13:"R-DME-1296065";s:31:"Inwardly rectifying K+ channels";s:13:"R-DME-1296071";s:18:"Potassium Channels";s:13:"R-DME-1059683";s:23:"Interleukin-6 signaling";s:13:"R-DME-6783589";s:30:"Interleukin-6 family signaling";s:13:"R-DME-1169091";s:34:"Activation of NF-kappaB in B cells";s:13:"R-DME-1168372";s:52:"Downstream signaling events of B Cell Receptor (BCR)";s:12:"R-DME-983705";s:38:"Signaling by the B Cell Receptor (BCR)";s:12:"R-DME-983695";s:82:"Antigen activates B Cell Receptor (BCR) leading to generation of second messengers";s:13:"R-DME-1169408";s:25:"ISG15 antiviral mechanism";s:13:"R-DME-1169410";s:43:"Antiviral mechanism by IFN-stimulated genes";s:13:"R-DME-6799990";s:45:"Metal sequestration by antimicrobial proteins";s:13:"R-DME-1538133";s:15:"G0 and Early G1";s:13:"R-DME-1234176";s:72:"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha";s:13:"R-DME-1234174";s:54:"Regulation of Hypoxia-inducible Factor (HIF) by oxygen";s:13:"R-DME-2262749";s:28:"Cellular response to hypoxia";s:13:"R-DME-1234158";s:57:"Regulation of gene expression by Hypoxia-inducible Factor";s:13:"R-DME-1236973";s:65:"Cross-presentation of particulate exogenous antigens (phagosomes)";s:13:"R-DME-1236975";s:37:"Antigen processing-Cross presentation";s:13:"R-DME-1236978";s:60:"Cross-presentation of soluble exogenous antigens (endosomes)";s:13:"R-DME-1237044";s:54:"Erythrocytes take up carbon dioxide and release oxygen";s:13:"R-DME-1480926";s:31:"O2/CO2 exchange in erythrocytes";s:13:"R-DME-1237112";s:26:"Methionine salvage pathway";s:13:"R-DME-1614635";s:28:"Sulfur amino acid metabolism";s:13:"R-DME-1247673";s:54:"Erythrocytes take up oxygen and release carbon dioxide";s:12:"R-DME-168638";s:24:"NOD1/2 Signaling Pathway";s:13:"R-DME-1250196";s:30:"SHC1 events in ERBB2 signaling";s:13:"R-DME-1227986";s:18:"Signaling by ERBB2";s:13:"R-DME-1250347";s:30:"SHC1 events in ERBB4 signaling";s:13:"R-DME-1236394";s:18:"Signaling by ERBB4";s:13:"R-DME-1251985";s:26:"Nuclear signaling by ERBB4";s:13:"R-DME-1253288";s:33:"Downregulation of ERBB4 signaling";s:13:"R-DME-1296025";s:32:"ATP sensitive Potassium channels";s:13:"R-DME-1296052";s:26:"Ca2+ activated K+ channels";s:13:"R-DME-1296061";s:12:"HCN channels";s:13:"R-DME-1296067";s:28:"Potassium transport channels";s:13:"R-DME-1296053";s:22:"Classical Kir channels";s:13:"R-DME-5576886";s:36:"Phase 4 - resting membrane potential";s:13:"R-DME-1296072";s:32:"Voltage gated Potassium channels";s:13:"R-DME-1299503";s:37:"TWIK related potassium channel (TREK)";s:13:"R-DME-1296346";s:37:"Tandem pore domain potassium channels";s:13:"R-DME-1300645";s:17:"Acrosome Reaction";s:13:"R-DME-1187000";s:13:"Fertilization";s:13:"R-DME-1474165";s:12:"Reproduction";s:13:"R-DME-1299316";s:46:"TWIK-releated acid-sensitive K+ channel (TASK)";s:13:"R-DME-1299344";s:43:"TWIK-related spinal cord K+ channel (TRESK)";s:13:"R-DME-1299361";s:52:"TWIK-related alkaline pH activated K+ channel (TALK)";s:13:"R-DME-1963640";s:30:"GRB2 events in ERBB2 signaling";s:13:"R-DME-1358803";s:39:"Downregulation of ERBB2:ERBB3 signaling";s:13:"R-DME-8863795";s:33:"Downregulation of ERBB2 signaling";s:13:"R-DME-1362409";s:44:"Mitochondrial iron-sulfur cluster biogenesis";s:13:"R-DME-1445148";s:45:"Translocation of GLUT4 to the plasma membrane";s:13:"R-DME-1474151";s:70:"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation";s:13:"R-DME-1475029";s:38:"Reversible hydration of carbon dioxide";s:13:"R-DME-1482788";s:28:"Acyl chain remodelling of PC";s:13:"R-DME-1482925";s:28:"Acyl chain remodelling of PG";s:13:"R-DME-1482922";s:28:"Acyl chain remodelling of PI";s:13:"R-DME-1483115";s:17:"Hydrolysis of LPC";s:13:"R-DME-1482801";s:28:"Acyl chain remodelling of PS";s:13:"R-DME-1482839";s:28:"Acyl chain remodelling of PE";s:13:"R-DME-1482883";s:36:"Acyl chain remodeling of DAG and TAG";s:13:"R-DME-1482798";s:27:"Acyl chain remodeling of CL";s:13:"R-DME-1483213";s:15:"Synthesis of PE";s:13:"R-DME-1483226";s:15:"Synthesis of PI";s:13:"R-DME-1483076";s:15:"Synthesis of CL";s:13:"R-DME-1483196";s:50:"PI and PC transport between ER and Golgi membranes";s:13:"R-DME-1483148";s:15:"Synthesis of PG";s:13:"R-DME-1483101";s:15:"Synthesis of PS";s:13:"R-DME-4641258";s:18:"Degradation of DVL";s:13:"R-DME-1474228";s:39:"Degradation of the extracellular matrix";s:13:"R-DME-1592389";s:39:"Activation of Matrix Metalloproteinases";s:13:"R-DME-1660662";s:28:"Glycosphingolipid metabolism";s:13:"R-DME-2024101";s:17:"CS/DS degradation";s:13:"R-DME-1793185";s:47:"Chondroitin sulfate/dermatan sulfate metabolism";s:13:"R-DME-1663150";s:32:"The activation of arylsulfatases";s:12:"R-DME-163841";s:68:"Gamma carboxylation, hypusine formation and arylsulfatase activation";s:13:"R-DME-1614603";s:36:"Cysteine formation from homocysteine";s:13:"R-DME-1614517";s:28:"Sulfide oxidation to sulfate";s:13:"R-DME-1614558";s:40:"Degradation of cysteine and homocysteine";s:13:"R-DME-2022857";s:27:"Keratan sulfate degradation";s:13:"R-DME-1632852";s:14:"Macroautophagy";s:13:"R-DME-1655829";s:55:"Regulation of cholesterol biosynthesis by SREBP (SREBF)";s:13:"R-DME-6811558";s:47:"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling";s:13:"R-DME-1660517";s:47:"Synthesis of PIPs at the late endosome membrane";s:13:"R-DME-1483248";s:36:"Synthesis of PIPs at the ER membrane";s:13:"R-DME-1660514";s:39:"Synthesis of PIPs at the Golgi membrane";s:13:"R-DME-1660516";s:48:"Synthesis of PIPs at the early endosome membrane";s:13:"R-DME-2024096";s:18:"HS-GAG degradation";s:13:"R-DME-1679131";s:43:"Trafficking and processing of endosomal TLR";s:13:"R-DME-1799339";s:59:"SRP-dependent cotranslational protein targeting to membrane";s:13:"R-DME-1855204";s:39:"Synthesis of IP3 and IP4 in the cytosol";s:13:"R-DME-1483249";s:29:"Inositol phosphate metabolism";s:13:"R-DME-1855183";s:44:"Synthesis of IP2, IP, and Ins in the cytosol";s:13:"R-DME-1855191";s:31:"Synthesis of IPs in the nucleus";s:13:"R-DME-1855167";s:42:"Synthesis of pyrophosphates in the cytosol";s:13:"R-DME-1855231";s:32:"Synthesis of IPs in the ER lumen";s:13:"R-DME-1971475";s:63:"A tetrasaccharide linker sequence is required for GAG synthesis";s:13:"R-DME-2122948";s:48:"Activated NOTCH1 Transmits Signal to the Nucleus";s:13:"R-DME-1980143";s:19:"Signaling by NOTCH1";s:13:"R-DME-1912420";s:29:"Pre-NOTCH Processing in Golgi";s:13:"R-DME-1912422";s:35:"Pre-NOTCH Expression and Processing";s:13:"R-DME-1268020";s:28:"Mitochondrial protein import";s:13:"R-DME-2022870";s:32:"Chondroitin sulfate biosynthesis";s:13:"R-DME-2979096";s:59:"NOTCH2 Activation and Transmission of Signal to the Nucleus";s:13:"R-DME-1980145";s:19:"Signaling by NOTCH2";s:13:"R-DME-1650814";s:43:"Collagen biosynthesis and modifying enzymes";s:13:"R-DME-1474290";s:18:"Collagen formation";s:13:"R-DME-2022923";s:29:"Dermatan sulfate biosynthesis";s:13:"R-DME-2243919";s:32:"Crosslinking of collagen fibrils";s:13:"R-DME-2022090";s:60:"Assembly of collagen fibrils and other multimeric structures";s:13:"R-DME-2025928";s:26:"Calcineurin activates NFAT";s:13:"R-DME-2028269";s:18:"Signaling by Hippo";s:13:"R-DME-5663213";s:36:"RHO GTPases Activate WASPs and WAVEs";s:13:"R-DME-2032785";s:48:"YAP1- and WWTR1 (TAZ)-stimulated gene expression";s:13:"R-DME-2046106";s:37:"alpha-linolenic acid (ALA) metabolism";s:13:"R-DME-2046104";s:62:"alpha-linolenic (omega3) and linoleic (omega6) acid metabolism";s:13:"R-DME-2046105";s:29:"Linoleic acid (LA) metabolism";s:13:"R-DME-2132295";s:33:"MHC class II antigen presentation";s:13:"R-DME-2173791";s:73:"TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)";s:13:"R-DME-2161541";s:19:"Abacavir metabolism";s:13:"R-DME-2161522";s:33:"Abacavir transport and metabolism";s:13:"R-DME-2161517";s:32:"Abacavir transmembrane transport";s:13:"R-DME-2142700";s:26:"Synthesis of Lipoxins (LX)";s:13:"R-DME-2142816";s:57:"Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)";s:13:"R-DME-2142670";s:65:"Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)";s:13:"R-DME-2142712";s:49:"Synthesis of 12-eicosatetraenoic acid derivatives";s:13:"R-DME-2142789";s:22:"Ubiquinol biosynthesis";s:13:"R-DME-2160916";s:33:"Hyaluronan uptake and degradation";s:13:"R-DME-2142845";s:21:"Hyaluronan metabolism";s:13:"R-DME-1442490";s:20:"Collagen degradation";s:13:"R-DME-2465910";s:37:"MASTL Facilitates Mitotic Progression";s:11:"R-DME-68875";s:16:"Mitotic Prophase";s:13:"R-DME-9013507";s:59:"NOTCH3 Activation and Transmission of Signal to the Nucleus";s:13:"R-DME-9012852";s:19:"Signaling by NOTCH3";s:13:"R-DME-3000471";s:31:"Scavenging by Class B Receptors";s:13:"R-DME-2173782";s:52:"Binding and Uptake of Ligands by Scavenger Receptors";s:12:"R-DME-162658";s:51:"Golgi Cisternae Pericentriolar Stack Reorganization";s:13:"R-DME-3000171";s:38:"Non-integrin membrane-ECM interactions";s:13:"R-DME-2393930";s:42:"Phosphate bond hydrolysis by NUDT proteins";s:13:"R-DME-2129379";s:40:"Molecules associated with elastic fibres";s:13:"R-DME-1566948";s:23:"Elastic fibre formation";s:13:"R-DME-2395516";s:43:"Electron transport from NADPH to Ferredoxin";s:13:"R-DME-3000178";s:17:"ECM proteoglycans";s:13:"R-DME-2408508";s:50:"Metabolism of ingested SeMet, Sec, MeSec into H2Se";s:13:"R-DME-2408522";s:27:"Selenoamino acid metabolism";s:13:"R-DME-2424491";s:15:"DAP12 signaling";s:13:"R-DME-2172127";s:18:"DAP12 interactions";s:13:"R-DME-2187335";s:45:"The retinoid cycle in cones (daylight vision)";s:13:"R-DME-2500257";s:39:"Resolution of Sister Chromatid Cohesion";s:11:"R-DME-68877";s:20:"Mitotic Prometaphase";s:13:"R-DME-2467813";s:31:"Separation of Sister Chromatids";s:11:"R-DME-68882";s:16:"Mitotic Anaphase";s:13:"R-DME-2555396";s:30:"Mitotic Metaphase and Anaphase";s:13:"R-DME-2468052";s:42:"Establishment of Sister Chromatid Cohesion";s:13:"R-DME-2470946";s:30:"Cohesin Loading onto Chromatin";s:13:"R-DME-2473224";s:36:"Antagonism of Activin by Follistatin";s:13:"R-DME-3000480";s:31:"Scavenging by Class A Receptors";s:13:"R-DME-2514853";s:40:"Condensation of Prometaphase Chromosomes";s:13:"R-DME-1300642";s:24:"Sperm Motility And Taxes";s:13:"R-DME-3000170";s:21:"Syndecan interactions";s:13:"R-DME-2672351";s:24:"Stimuli-sensing channels";s:13:"R-DME-2871809";s:32:"FCERI mediated Ca+2 mobilization";s:13:"R-DME-5607763";s:41:"CLEC7A (Dectin-1) induces NFAT activation";s:13:"R-DME-5607764";s:27:"CLEC7A (Dectin-1) signaling";s:13:"R-DME-5621481";s:30:"C-type lectin receptors (CLRs)";s:13:"R-DME-4086398";s:12:"Ca2+ pathway";s:13:"R-DME-3858494";s:38:"Beta-catenin independent WNT signaling";s:12:"R-DME-977606";s:32:"Regulation of Complement cascade";s:13:"R-DME-3065679";s:33:"SUMO is proteolytically processed";s:13:"R-DME-3215018";s:33:"Processing and activation of SUMO";s:13:"R-DME-2990846";s:11:"SUMOylation";s:13:"R-DME-3301854";s:38:"Nuclear Pore Complex (NPC) Disassembly";s:13:"R-DME-2980766";s:26:"Nuclear Envelope Breakdown";s:13:"R-DME-2995383";s:42:"Initiation of Nuclear Envelope Reformation";s:13:"R-DME-2995410";s:27:"Nuclear Envelope Reassembly";s:13:"R-DME-2565942";s:46:"Regulation of PLK1 Activity at G2/M Transition";s:12:"R-DME-196741";s:53:"Cobalamin (Cbl, vitamin B12) transport and metabolism";s:13:"R-DME-3134973";s:72:"LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production";s:13:"R-DME-2559585";s:27:"Oncogene Induced Senescence";s:13:"R-DME-3214842";s:25:"HDMs demethylate histones";s:13:"R-DME-3247509";s:27:"Chromatin modifying enzymes";s:13:"R-DME-4839726";s:22:"Chromatin organization";s:13:"R-DME-3214858";s:32:"RMTs methylate histone arginines";s:13:"R-DME-3238698";s:37:"WNT ligand biogenesis and trafficking";s:13:"R-DME-3249367";s:38:"STAT6-mediated induction of chemokines";s:13:"R-DME-1834941";s:49:"STING mediated induction of host immune responses";s:13:"R-DME-3295583";s:12:"TRP channels";s:12:"R-DME-201722";s:57:"Formation of the beta-catenin:TCF transactivating complex";s:13:"R-DME-3214847";s:23:"HATs acetylate histones";s:13:"R-DME-3769402";s:56:"Deactivation of the beta-catenin transactivating complex";s:13:"R-DME-3371497";s:57:"HSP90 chaperone cycle for steroid hormone receptors (SHR)";s:13:"R-DME-3371453";s:47:"Regulation of HSF1-mediated heat shock response";s:13:"R-DME-3371556";s:32:"Cellular response to heat stress";s:13:"R-DME-3371511";s:15:"HSF1 activation";s:13:"R-DME-3371568";s:17:"Attenuation phase";s:13:"R-DME-3371571";s:30:"HSF1-dependent transactivation";s:13:"R-DME-3232118";s:36:"SUMOylation of transcription factors";s:13:"R-DME-3108232";s:41:"SUMO E3 ligases SUMOylate target proteins";s:13:"R-DME-4641257";s:19:"Degradation of AXIN";s:12:"R-DME-201688";s:30:"WNT mediated activation of DVL";s:13:"R-DME-2559586";s:45:"DNA Damage/Telomere Stress Induced Senescence";s:13:"R-DME-4086400";s:14:"PCP/CE pathway";s:13:"R-DME-5663220";s:28:"RHO GTPases Activate Formins";s:13:"R-DME-3928662";s:31:"EPHB-mediated forward signaling";s:13:"R-DME-2682334";s:20:"EPH-Ephrin signaling";s:13:"R-DME-3928665";s:38:"EPH-ephrin mediated repulsion of cells";s:13:"R-DME-3928664";s:16:"Ephrin signaling";s:13:"R-DME-3928663";s:34:"EPHA-mediated growth cone collapse";s:13:"R-DME-4419969";s:38:"Depolymerisation of the Nuclear Lamina";s:13:"R-DME-3108214";s:54:"SUMOylation of DNA damage response and repair proteins";s:13:"R-DME-4551638";s:46:"SUMOylation of chromatin organization proteins";s:13:"R-DME-4570464";s:35:"SUMOylation of RNA binding proteins";s:13:"R-DME-4608870";s:39:"Asymmetric localization of PCP proteins";s:13:"R-DME-4641265";s:30:"Repression of WNT target genes";s:13:"R-DME-4615885";s:39:"SUMOylation of DNA replication proteins";s:13:"R-DME-3214841";s:31:"PKMTs methylate histone lysines";s:13:"R-DME-5099900";s:39:"WNT5A-dependent internalization of FZD4";s:13:"R-DME-5173214";s:49:"O-glycosylation of TSR domain-containing proteins";s:13:"R-DME-5205685";s:30:"Pink/Parkin Mediated Mitophagy";s:13:"R-DME-5205647";s:9:"Mitophagy";s:13:"R-DME-5218921";s:34:"VEGFR2 mediated cell proliferation";s:13:"R-DME-5221030";s:32:"TET1,2,3 and TDG demethylate DNA";s:12:"R-DME-381038";s:33:"XBP1(S) activates chaperone genes";s:12:"R-DME-375276";s:32:"Peptide ligand-binding receptors";s:13:"R-DME-5223345";s:42:"Miscellaneous transport and binding events";s:13:"R-DME-5358346";s:26:"Hedgehog ligand biogenesis";s:13:"R-DME-5358351";s:21:"Signaling by Hedgehog";s:13:"R-DME-5358493";s:29:"Synthesis of diphthamide-EEF2";s:13:"R-DME-5358565";s:55:"Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)";s:13:"R-DME-5358508";s:15:"Mismatch Repair";s:13:"R-DME-5358606";s:54:"Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)";s:13:"R-DME-5362798";s:40:"Release of Hh-Np from the secreting cell";s:13:"R-DME-5389840";s:36:"Mitochondrial translation elongation";s:13:"R-DME-5368287";s:25:"Mitochondrial translation";s:13:"R-DME-5419276";s:37:"Mitochondrial translation termination";s:13:"R-DME-5576894";s:43:"Phase 1 - inactivation of fast Na+ channels";s:13:"R-DME-5578749";s:40:"Transcriptional regulation by small RNAs";s:13:"R-DME-5607761";s:46:"Dectin-1 mediated noncanonical NF-kB signaling";s:13:"R-DME-5676590";s:34:"NIK-->noncanonical NF-kB signaling";s:13:"R-DME-5668541";s:33:"TNFR2 non-canonical NF-kB pathway";s:13:"R-DME-5610785";s:44:"GLI3 is processed to GLI3R by the proteasome";s:13:"R-DME-5610787";s:20:"Hedgehog 'off' state";s:13:"R-DME-5632684";s:19:"Hedgehog 'on' state";s:13:"R-DME-5610780";s:37:"Degradation of GLI1 by the proteasome";s:13:"R-DME-5620924";s:24:"Intraflagellar transport";s:13:"R-DME-5617833";s:15:"Cilium Assembly";s:13:"R-DME-1852241";s:36:"Organelle biogenesis and maintenance";s:13:"R-DME-5620916";s:30:"VxPx cargo-targeting to cilium";s:13:"R-DME-5620920";s:45:"Cargo trafficking to the periciliary membrane";s:13:"R-DME-5624138";s:51:"Trafficking of myristoylated proteins to the cilium";s:13:"R-DME-5621575";s:25:"CD209 (DC-SIGN) signaling";s:13:"R-DME-5624958";s:45:"ARL13B-mediated ciliary trafficking of INPP5E";s:13:"R-DME-5632681";s:28:"Ligand-receptor interactions";s:13:"R-DME-5635838";s:17:"Activation of SMO";s:13:"R-DME-5357905";s:29:"Regulation of TNFR1 signaling";s:11:"R-DME-75893";s:13:"TNF signaling";s:11:"R-DME-73887";s:25:"Death Receptor Signalling";s:12:"R-DME-110362";s:46:"POLB-Dependent Long Patch Base Excision Repair";s:12:"R-DME-110314";s:64:"Recognition of DNA damage by PCNA-containing replication complex";s:13:"R-DME-5652227";s:21:"Fructose biosynthesis";s:13:"R-DME-5656169";s:40:"Termination of translesion DNA synthesis";s:13:"R-DME-5653890";s:17:"Lactose synthesis";s:13:"R-DME-5654221";s:39:"Phospholipase C-mediated cascade; FGFR2";s:13:"R-DME-5654227";s:39:"Phospholipase C-mediated cascade; FGFR3";s:13:"R-DME-5654219";s:39:"Phospholipase C-mediated cascade: FGFR1";s:13:"R-DME-5654228";s:39:"Phospholipase C-mediated cascade; FGFR4";s:13:"R-DME-5654693";s:28:"FRS-mediated FGFR1 signaling";s:13:"R-DME-5654700";s:28:"FRS-mediated FGFR2 signaling";s:13:"R-DME-5654699";s:26:"SHC-mediated cascade:FGFR2";s:13:"R-DME-5654706";s:28:"FRS-mediated FGFR3 signaling";s:13:"R-DME-5654712";s:28:"FRS-mediated FGFR4 signaling";s:13:"R-DME-5654719";s:26:"SHC-mediated cascade:FGFR4";s:13:"R-DME-5658623";s:36:"FGFRL1 modulation of FGFR1 signaling";s:13:"R-DME-5654688";s:26:"SHC-mediated cascade:FGFR1";s:13:"R-DME-5654704";s:26:"SHC-mediated cascade:FGFR3";s:13:"R-DME-5655862";s:29:"Translesion synthesis by POLK";s:13:"R-DME-5656121";s:29:"Translesion synthesis by POLI";s:13:"R-DME-5658442";s:25:"Regulation of RAS by GAPs";s:13:"R-DME-5673001";s:22:"RAF/MAP kinase cascade";s:13:"R-DME-5661270";s:49:"Catabolism of glucuronate to xylulose-5-phosphate";s:13:"R-DME-5689603";s:15:"UCH proteinases";s:13:"R-DME-5666185";s:44:"RHO GTPases Activate Rhotekin and Rhophilins";s:13:"R-DME-5625900";s:24:"RHO GTPases activate CIT";s:13:"R-DME-5673000";s:14:"RAF activation";s:13:"R-DME-5674135";s:25:"MAP2K and MAPK activation";s:13:"R-DME-5675221";s:35:"Negative regulation of MAPK pathway";s:13:"R-DME-5674499";s:44:"Negative feedback regulation of MAPK pathway";s:13:"R-DME-5675482";s:36:"Regulation of necroptotic cell death";s:13:"R-DME-5213460";s:33:"RIPK1-mediated regulated necrosis";s:13:"R-DME-5218859";s:18:"Regulated Necrosis";s:13:"R-DME-5676934";s:14:"Protein repair";s:13:"R-DME-8963896";s:12:"HDL assembly";s:13:"R-DME-5693565";s:105:"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks";s:13:"R-DME-5682910";s:21:"LGI-ADAM interactions";s:13:"R-DME-5693607";s:42:"Processing of DNA double-strand break ends";s:13:"R-DME-5693567";s:74:"HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)";s:13:"R-DME-5693538";s:24:"Homology Directed Repair";s:13:"R-DME-5693616";s:63:"Presynaptic phase of homologous DNA pairing and strand exchange";s:13:"R-DME-5693579";s:42:"Homologous DNA Pairing and Strand Exchange";s:13:"R-DME-5685942";s:42:"HDR through Homologous Recombination (HRR)";s:13:"R-DME-2428933";s:37:"SHC-related events triggered by IGF1R";s:13:"R-DME-5693568";s:71:"Resolution of D-loop Structures through Holliday Junction Intermediates";s:13:"R-DME-5693537";s:31:"Resolution of D-Loop Structures";s:13:"R-DME-5693571";s:32:"Nonhomologous End-Joining (NHEJ)";s:13:"R-DME-5687128";s:21:"MAPK6/MAPK4 signaling";s:13:"R-DME-5685939";s:27:"HDR through MMEJ (alt-NHEJ)";s:13:"R-DME-2151201";s:54:"Transcriptional activation of mitochondrial biogenesis";s:13:"R-DME-1592230";s:24:"Mitochondrial biogenesis";s:13:"R-DME-5689877";s:20:"Josephin domain DUBs";s:13:"R-DME-6799198";s:20:"Complex I biogenesis";s:13:"R-DME-5696400";s:23:"Dual Incision in GG-NER";s:13:"R-DME-8951664";s:11:"Neddylation";s:13:"R-DME-5689896";s:30:"Ovarian tumor domain proteases";s:13:"R-DME-5696397";s:55:"Gap-filling DNA repair synthesis and ligation in GG-NER";s:13:"R-DME-5696394";s:32:"DNA Damage Recognition in GG-NER";s:13:"R-DME-5689901";s:20:"Metalloprotease DUBs";s:13:"R-DME-6783984";s:19:"Glycine degradation";s:13:"R-DME-8963889";s:48:"Assembly of active LPL and LIPC lipase complexes";s:13:"R-DME-5694530";s:29:"Cargo concentration in the ER";s:12:"R-DME-193144";s:21:"Estrogen biosynthesis";s:13:"R-DME-6781823";s:40:"Formation of TC-NER Pre-Incision Complex";s:13:"R-DME-6781827";s:57:"Transcription-Coupled Nucleotide Excision Repair (TC-NER)";s:13:"R-DME-6782135";s:23:"Dual incision in TC-NER";s:13:"R-DME-6782210";s:55:"Gap-filling DNA repair synthesis and ligation in TC-NER";s:13:"R-DME-6783783";s:24:"Interleukin-10 signaling";s:13:"R-DME-8854691";s:31:"Interleukin-20 family signaling";s:13:"R-DME-6783310";s:22:"Fanconi Anemia Pathway";s:13:"R-DME-6785631";s:29:"ERBB2 Regulates Cell Motility";s:13:"R-DME-6785807";s:30:"Interleukin-4 and 13 signaling";s:13:"R-DME-8876725";s:19:"Protein methylation";s:13:"R-DME-6809371";s:35:"Formation of the cornified envelope";s:13:"R-DME-6805567";s:14:"Keratinization";s:13:"R-DME-6791226";s:61:"Major pathway of rRNA processing in the nucleolus and cytosol";s:13:"R-DME-8868773";s:42:"rRNA processing in the nucleus and cytosol";s:11:"R-DME-72312";s:15:"rRNA processing";s:13:"R-DME-6794361";s:25:"Neurexins and neuroligins";s:13:"R-DME-6796648";s:48:"TP53 Regulates Transcription of DNA Repair Genes";s:13:"R-DME-6798163";s:18:"Choline catabolism";s:13:"R-DME-6804115";s:112:"TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain";s:13:"R-DME-6791312";s:48:"TP53 Regulates Transcription of Cell Cycle Genes";s:13:"R-DME-5668599";s:35:"RHO GTPases Activate NADPH Oxidases";s:13:"R-DME-6804756";s:51:"Regulation of TP53 Activity through Phosphorylation";s:13:"R-DME-5633007";s:27:"Regulation of TP53 Activity";s:13:"R-DME-6798695";s:24:"Neutrophil degranulation";s:11:"R-DME-72764";s:34:"Eukaryotic Translation Termination";s:13:"R-DME-6803205";s:132:"TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain";s:13:"R-DME-5633008";s:48:"TP53 Regulates Transcription of Cell Death Genes";s:13:"R-DME-6803204";s:70:"TP53 Regulates Transcription of Genes Involved in Cytochrome C Release";s:13:"R-DME-6803529";s:26:"FGFR2 alternative splicing";s:13:"R-DME-6804114";s:70:"TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest";s:13:"R-DME-5686938";s:38:"Regulation of TLR by endogenous ligand";s:13:"R-DME-6804758";s:47:"Regulation of TP53 Activity through Acetylation";s:13:"R-DME-6804759";s:63:"Regulation of TP53 Activity through Association with Co-factors";s:13:"R-DME-6807062";s:40:"Cholesterol biosynthesis via lathosterol";s:13:"R-DME-8948747";s:31:"Regulation of PTEN localization";s:13:"R-DME-6807070";s:15:"PTEN Regulation";s:13:"R-DME-8948751";s:41:"Regulation of PTEN stability and activity";s:13:"R-DME-6807878";s:35:"COPI-mediated anterograde transport";s:13:"R-DME-6807505";s:41:"RNA polymerase II transcribes snRNA genes";s:13:"R-DME-6811555";s:31:"PI5P Regulates TP53 Acetylation";s:13:"R-DME-8847453";s:32:"Synthesis of PIPs in the nucleus";s:13:"R-DME-6811434";s:45:"COPI-dependent Golgi-to-ER retrograde traffic";s:13:"R-DME-8856688";s:32:"Golgi-to-ER retrograde transport";s:13:"R-DME-6811442";s:46:"Intra-Golgi and retrograde Golgi-to-ER traffic";s:13:"R-DME-6811440";s:47:"Retrograde transport at the Trans-Golgi-Network";s:13:"R-DME-6811438";s:19:"Intra-Golgi traffic";s:13:"R-DME-6814848";s:30:"Glycerophospholipid catabolism";s:13:"R-DME-6814122";s:66:"Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding";s:13:"R-DME-6811436";s:47:"COPI-independent Golgi-to-ER retrograde traffic";s:13:"R-DME-8849471";s:54:"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases";s:13:"R-DME-8848021";s:17:"Signaling by PTK6";s:13:"R-DME-9006927";s:42:"Signaling by Non-Receptor Tyrosine Kinases";s:13:"R-DME-8849469";s:53:"PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1";s:13:"R-DME-8849468";s:50:"PTK6 Regulates Proteins Involved in RNA Processing";s:13:"R-DME-8850843";s:45:"Phosphate bond hydrolysis by NTPDase proteins";s:13:"R-DME-8866652";s:57:"Synthesis of active ubiquitin: roles of E1 and E2 enzymes";s:13:"R-DME-8852135";s:22:"Protein ubiquitination";s:13:"R-DME-8854050";s:68:"FBXL7 down-regulates AURKA during mitotic entry and in early mitosis";s:13:"R-DME-8853383";s:36:"Lysosomal oligosaccharide catabolism";s:13:"R-DME-8854214";s:11:"TBC/RABGAPs";s:13:"R-DME-9007101";s:29:"Rab regulation of trafficking";s:13:"R-DME-8866427";s:37:"VLDLR internalisation and degradation";s:13:"R-DME-8866376";s:25:"Reelin signalling pathway";s:13:"R-DME-8856828";s:29:"Clathrin-mediated endocytosis";s:13:"R-DME-8964572";s:27:"Lipid particle organization";s:13:"R-DME-8856825";s:51:"Cargo recognition for clathrin-mediated endocytosis";s:13:"R-DME-8866907";s:62:"Activation of the TFAP2 (AP-2) family of transcription factors";s:13:"R-DME-8864260";s:78:"Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors";s:13:"R-DME-8866904";s:76:"Negative regulation of activity of TFAP2 (AP-2) family transcription factors";s:13:"R-DME-8866911";s:65:"TFAP2 (AP-2) family regulates transcription of cell cycle factors";s:13:"R-DME-8934593";s:43:"Regulation of RUNX1 Expression and Activity";s:13:"R-DME-8878171";s:35:"Transcriptional regulation by RUNX1";s:13:"R-DME-8941858";s:43:"Regulation of RUNX3 expression and activity";s:13:"R-DME-8878159";s:35:"Transcriptional regulation by RUNX3";s:13:"R-DME-8939236";s:74:"RUNX1 regulates transcription of genes involved in differentiation of HSCs";s:13:"R-DME-8866423";s:13:"VLDL assembly";s:13:"R-DME-8873719";s:23:"RAB geranylgeranylation";s:13:"R-DME-8877627";s:9:"Vitamin E";s:13:"R-DME-8876198";s:37:"RAB GEFs exchange GTP for GDP on RABs";s:13:"R-DME-8941326";s:32:"RUNX2 regulates bone development";s:13:"R-DME-8878166";s:35:"Transcriptional regulation by RUNX2";s:13:"R-DME-8939243";s:82:"RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known";s:13:"R-DME-8941855";s:36:"RUNX3 regulates CDKN1A transcription";s:13:"R-DME-8936459";s:85:"RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function";s:13:"R-DME-8937144";s:36:"Aryl hydrocarbon receptor signalling";s:13:"R-DME-8939246";s:83:"RUNX1 regulates transcription of genes involved in differentiation of myeloid cells";s:13:"R-DME-8866654";s:49:"E3 ubiquitin ligases ubiquitinate target proteins";s:13:"R-DME-8939247";s:72:"RUNX1 regulates transcription of genes involved in interleukin signaling";s:13:"R-DME-8939245";s:64:"RUNX1 regulates transcription of genes involved in BCR signaling";s:13:"R-DME-8939902";s:43:"Regulation of RUNX2 expression and activity";s:13:"R-DME-8943724";s:37:"Regulation of PTEN gene transcription";s:13:"R-DME-8948216";s:28:"Collagen chain trimerization";s:13:"R-DME-8934903";s:27:"Receptor Mediated Mitophagy";s:13:"R-DME-8949215";s:35:"Mitochondrial calcium ion transport";s:13:"R-DME-8949613";s:17:"Cristae formation";s:13:"R-DME-8949664";s:19:"Processing of SMDT1";s:13:"R-DME-9020591";s:24:"Interleukin-12 signaling";s:12:"R-DME-447115";s:31:"Interleukin-12 family signaling";s:13:"R-DME-8984722";s:25:"Interleukin-35 Signalling";s:13:"R-DME-9020933";s:24:"Interleukin-23 signaling";s:13:"R-DME-9020956";s:24:"Interleukin-27 signaling";s:13:"R-DME-8951430";s:29:"RUNX3 regulates WNT signaling";s:13:"R-DME-8951671";s:43:"RUNX3 regulates YAP1-mediated transcription";s:13:"R-DME-8951936";s:23:"RUNX3 regulates p14-ARF";s:12:"R-DME-381426";s:123:"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)";s:13:"R-DME-8957275";s:42:"Post-translational protein phosphorylation";s:13:"R-DME-8953750";s:34:"Transcriptional Regulation by E2F6";s:13:"R-DME-2408557";s:24:"Selenocysteine synthesis";s:12:"R-DME-192456";s:26:"Digestion of dietary lipid";s:13:"R-DME-8983432";s:24:"Interleukin-15 signaling";s:13:"R-DME-9010553";s:43:"Regulation of expression of SLITs and ROBOs";s:13:"R-DME-9007892";s:24:"Interleukin-38 signaling";s:13:"R-DME-9008059";s:24:"Interleukin-37 signaling";s:13:"R-DME-9017802";s:33:"Noncanonical activation of NOTCH3";}